{"content":"<li class=\"n-box-item date-title\" data-end=\"1378267199\" data-start=\"1378180800\" data-txt=\"Friday, December 20, 2019\">Tuesday, September  3, 2013</li><li class=\"n-box-item sa-box-item\" data-id=\"1258672\" data-ts=\"1378244151\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1258672-after-hours-top-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After-hours top gainers / Losers</a></h4><ul>     <li><b>After-hours top gainers, as of 5:15 p.m.:</b> <a href='https://seekingalpha.com/symbol/SPA' title='Sparton Corporation'>SPA</a> <font color='green'>+14%</font>. CADX <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/GWRE' title='Guidewire Software, Inc.'>GWRE</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/SPPI' title='Spectrum Pharmaceuticals, Inc.'>SPPI</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/ALEX' title='Alexander & Baldwin, Inc.'>ALEX</a> <font color='green'>+4%</font>.</li><li><b>After-hours top losers:</b> <a href='https://seekingalpha.com/symbol/INFN' title='Infinera Corporation'>INFN</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/NBIX' title='Neurocrine Biosciences, Inc.'>NBIX</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/INFI' title='Infinity Pharmaceuticals, Inc.'>INFI</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/FES' title='Forbes Energy Services Ltd.'>FES</a> <font color='red'>-4%</font>. <a href='https://seekingalpha.com/symbol/MBI' title='MBIA Inc.'>MBI</a> <font color='red'>-4%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1258672\" data-linked=\"After-hours top gainers / Losers\" data-tweet=\"$SPA $MNK $GWRE - After-hours top gainers / Losers https://seekingalpha.com/news/1258672-after-hours-top-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1258672-after-hours-top-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1258652\" data-ts=\"1378243716\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPA\" target=\"_blank\">SPA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1258652-sparton-climbs-ah-on-fq4-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sparton climbs AH on FQ4 beat</a></h4><ul>     <li>Shares of Sparton (NYSE:<a href=\"https://seekingalpha.com/symbol/SPA\" title=\"Sparton Corporation\">SPA</a>) are <font color=\"green\">up 13.6%</font> AH following the company's <a href=\"https://seekingalpha.com/currents/post/1258412\" target=\"_blank\">FQ4 beat</a>.</li>     <li>Sparton ended the quarter with a sales backlog of $199.8M, including $31.9M from newly-acquired Onyx EMS, representing a 35% Y/Y increase. (PR)</li>     <li>Medical Devices revenue grew $3.4M from FQ4 2012, Complex Systems $0.8M (7%), and Defense &amp; Security Systems $8.3M (40%).</li>     <li>The acquisition of the Onyx medical business resulted in revenue of $13.1M, EBITDA of $1.7M, and operating income of $0.6M.</li>     <li>\n<a href=\"https://www149.livemeeting.com/cc/gc_min_pro_usa/join?id=4RSNBJ&amp;role=attend\" target=\"_blank\">Conference call</a> scheduled for 11 am ET tomorrow</li> </ul><div class=\"tiny-share-widget\" data-id=\"1258652\" data-linked=\"Sparton climbs AH on FQ4 beat\" data-tweet=\"$SPA - Sparton climbs AH on FQ4 beat https://seekingalpha.com/news/1258652-sparton-climbs-ah-on-fq4-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/1258652-sparton-climbs-ah-on-fq4-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:28 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1258552\" data-ts=\"1378242421\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XONE\" target=\"_blank\">XONE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1258552-exone-announces-public-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ExOne announces public offering</a></h4><ul>\n<li>ExOne (NASDAQ:<a href=\"https://seekingalpha.com/symbol/XONE\" title=\"ExOne\">XONE</a>) says it's launched a 2.656M share public offering, of which 1,106,000 shares will be sold by <a href=\"https://seekingalpha.com/symbol/XONE\" title=\"ExOne\">XONE</a> and 1,550,000 shares by certain shareholders.</li>\n<li>The underwriters will have an option to purchase up to an additional 398,400 shares from certain of the selling stockholders.</li>\n<li>The company anticipates pricing the offering during the week of September 9.</li>\n<li>Shares <font color=\"red\">-1.8%</font> AH.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1258552\" data-linked=\"ExOne announces public offering\" data-tweet=\"$XONE - ExOne announces public offering https://seekingalpha.com/news/1258552-exone-announces-public-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/1258552-exone-announces-public-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1258432\" data-ts=\"1378240668\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HAIN\" target=\"_blank\">HAIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1258432-hain-celestial-falls-ah-after-icahn-reduces-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hain Celestial falls AH after Icahn reduces stake</a></h4><ul>     <li>Hain Celestial (NASDAQ:<a href=\"https://seekingalpha.com/symbol/HAIN\" title=\"The Hain Celestial Group, Inc.\">HAIN</a>) shares are <font color=\"red\">down 2.9%</font> AH after the company discloses that Carl Icahn has sold 3.65M shares, more than halving his stake to 3.59M (7.5% of outstanding stock).</li>     <li>Jefferies will act as underwriter for the sale and has the option to purchase an additional 547.5K shares within 30 days. (<a href=\"http://www.sec.gov/Archives/edgar/data/910406/000091040613000025/freewritingprospectusdated.htm\" target=\"_blank\">FWP</a>)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1258432\" data-linked=\"Hain Celestial falls AH after Icahn reduces stake\" data-tweet=\"$HAIN - Hain Celestial falls AH after Icahn reduces stake https://seekingalpha.com/news/1258432-hain-celestial-falls-ah-after-icahn-reduces-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/1258432-hain-celestial-falls-ah-after-icahn-reduces-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1258372\" data-ts=\"1378240118\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELLI\" target=\"_blank\">ELLI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1258372-reuters-ellie-mae-hires-morgan-stanley-to-help-sell-company\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Ellie Mae hires Morgan Stanley to help sell company</a></h4><ul>\n<li>\n<a href=\"http://www.reuters.com/article/2013/09/03/us-elliemae-sale-idUSBRE98210J20130903?feedType=RSS&amp;feedName=innovationNews&amp;rpc=43\" target=\"_blank\">Sources claim</a> Ellie Mae's (<a href=\"https://seekingalpha.com/symbol/ELLI\" title=\"Ellie Mae, Inc.\">ELLI</a> <font color=\"green\">+3.2%</font>) sales process is \"expected to begin in the next few weeks, and a number of parties, particularly private equity firms, are expected to take a look.\"</li>\n<li>\n<a href=\"https://seekingalpha.com/currents/post/1209282\" target=\"_blank\">Bloomberg reported</a> a month ago the mortgage origination software vendor is \"considering a sale and has interviewed banks to manage the process.\"</li>\n<li>Ellie Mae spiked higher just before the close thanks to Reuters' report. Shares are 8% below their 52-week high of $32.61 (set after Bloomberg's report).</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1258372\" data-linked=\"Reuters: Ellie Mae hires Morgan Stanley to help sell company\" data-tweet=\"$ELLI - Reuters: Ellie Mae hires Morgan Stanley to help sell company https://seekingalpha.com/news/1258372-reuters-ellie-mae-hires-morgan-stanley-to-help-sell-company?source=tweet\" data-url=\"https://seekingalpha.com/news/1258372-reuters-ellie-mae-hires-morgan-stanley-to-help-sell-company\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:28 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1258342\" data-ts=\"1378239926\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GWRE\" target=\"_blank\">GWRE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1258342-guidewire-jumps-ah-on-fq4-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Guidewire jumps AH on FQ4 beat</a></h4><ul>\n<li>Guidewire Software (NYSE:<a href=\"https://seekingalpha.com/symbol/GWRE\" title=\"Guidewire Software, Inc.\">GWRE</a>) shares are up <font color=\"green\">10.9% AH</font> following the insurance software provider's <a href=\"https://seekingalpha.com/currents/post/1258232\" target=\"_blank\">FQ4 beat</a>. (PR)</li>\n<li>License revenue grew 70% Y/Y in FQ4 to $49.1M. Maintenance revenue grew 26% to $9.9M. Services revenue was up 23% to $38M.</li>\n<li>Gross margin expanded to 62% in FQ4 from 59.7% in FQ4 2012.</li>\n<li>Opex grew 25.1% Y/Y, led by R&amp;D expense growth of 31.3%.</li>\n<li>Adjusted EBITDA shot up 167.3% Y/Y to $27.8M.</li>\n<li>\n<a href=\"http://edge.media-server.com/m/p/uwdz7m2y/lan/en\" target=\"_blank\">Conference call </a>scheduled for 5pm ET</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1258342\" data-linked=\"Guidewire jumps AH on FQ4 beat\" data-tweet=\"$GWRE - Guidewire jumps AH on FQ4 beat https://seekingalpha.com/news/1258342-guidewire-jumps-ah-on-fq4-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/1258342-guidewire-jumps-ah-on-fq4-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1258232\" data-ts=\"1378239116\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GWRE\" target=\"_blank\">GWRE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1258232-guidewire-software-beats-by-0_11-betas-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Guidewire Software  beats by $0.11, betas on revenue</a></h4><ul>     <li>Guidewire Software (NYSE:<a href=\"https://seekingalpha.com/symbol/GWRE\" title=\"Guidewire Software, Inc.\">GWRE</a>): FQ4 EPS of $0.25 <font color=\"green\">beats by $0.11</font>.</li>\n<li>Revenue of $96.9M (+43% Y/Y) <font color=\"green\">beats by $3.8M</font>. Shares  <font color=\"green\">+7.57%</font> AH. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1258232\" data-linked=\"Guidewire Software  beats by $0.11, betas on revenue\" data-tweet=\"$GWRE - Guidewire Software beats by $0.11, betas on revenue https://seekingalpha.com/news/1258232-guidewire-software-beats-by-0_11-betas-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/1258232-guidewire-software-beats-by-0_11-betas-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1258222\" data-ts=\"1378239085\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSFT\" target=\"_blank\">MSFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1258222-linkedin-announces-1b-stock-offering-shares-minus-2_3-percent-ah\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LinkedIn announces $1B stock offering, shares -2.3% AH</a></h4><ul>\n<li>LinkedIn (LNKD) is offering $1B worth of Class A shares, with a $150M underwriter option. At current levels, the offering would increase the company's diluted share count by 3%, and its float by 4.5%. (PR) (<a href=\"http://www.sec.gov/Archives/edgar/data/1271024/000104746913008826/a2216551zs-3asr.htm\" target=\"_blank\">S-3</a>)</li>\n<li>The professional social networking kingpin says it's looking to increase its \"financial flexibility\" and \"further strengthen its balance sheet.\" With $873M in cash/investments at the end of Q2 and no debt, LinkedIn's balance sheet is already pretty strong. Is the company looking to make a big acquisition?</li>\n<li>Previous acquisitions: <a href=\"https://seekingalpha.com/currents/post/938941\" target=\"_blank\">Pulse</a>, SlideShare</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1258222\" data-linked=\"LinkedIn announces $1B stock offering, shares -2.3% AH\" data-tweet=\"$MSFT - LinkedIn announces $1B stock offering, shares -2.3% AH https://seekingalpha.com/news/1258222-linkedin-announces-1b-stock-offering-shares-minus-2_3-percent-ah?source=tweet\" data-url=\"https://seekingalpha.com/news/1258222-linkedin-announces-1b-stock-offering-shares-minus-2_3-percent-ah\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1258192\" data-ts=\"1378238348\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAT\" target=\"_blank\">CAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1258192-miner-cost-cutting-to-continue-cowen-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Miner cost cutting to continue, Cowen Says</a></h4><ul>     <li>Big miners are rallying today as <a href=\"https://seekingalpha.com/currents/post/1255532\" target=\"_blank\">China\u2019s economy shows signs of life</a> but Cowen analysts warn it would be foolish for investors to assume that commodity prices will soar back to their previous levels, if only because mining companies have been <a href=\"http://blogs.barrons.com/stockstowatchtoday/2013/09/03/miner-cost-cutting-to-continue-cowen-says/\" target=\"_blank\">cutting costs as if they expect prices will stay low</a>.</li>     <li>The rush to cut costs has been felt the hardest by mining-industry suppliers, including Caterpillar (<a href=\"https://seekingalpha.com/symbol/CAT\" title=\"Caterpillar Inc.\">CAT</a> <font color=\"red\">-0.1%</font>) and Joy Global (<a href=\"https://seekingalpha.com/symbol/JOY\" title=\"Joy Global Inc.\">JOY</a> <font color=\"green\">+0.9%</font>), Cowen says, because cancelling orders for new equipment is one of the easiest ways to cut costs.</li>     <li>Among S&amp;P 500 mining stocks, <a href=\"https://seekingalpha.com/symbol/FCX\" title=\"Freeport-McMoRan Inc.\">FCX</a> <font color=\"green\">+2.9%</font>, <a href=\"https://seekingalpha.com/symbol/CNX\" title=\"CNX Resources Corporation\">CNX</a> <font color=\"green\">+2.6%</font>, <a href=\"https://seekingalpha.com/symbol/NEM\" title=\"Newmont Mining Corporation (Holding Company)\">NEM</a> <font color=\"red\">-0.2%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1258192\" data-linked=\"Miner cost cutting to continue, Cowen Says\" data-tweet=\"$CAT $CAT $JOY - Miner cost cutting to continue, Cowen Says https://seekingalpha.com/news/1258192-miner-cost-cutting-to-continue-cowen-says?source=tweet\" data-url=\"https://seekingalpha.com/news/1258192-miner-cost-cutting-to-continue-cowen-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1258082\" data-ts=\"1378237956\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GIB\" target=\"_blank\">GIB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1258082-cgi-group-tumbles-on-deutsche-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CGI Group tumbles on Deutsche downgrade</a></h4><ul><li>CGI Group (<a href=\"https://seekingalpha.com/symbol/GIB\" title=\"CGI Group Inc.\">GIB</a> <font color=\"red\">-4.3%</font>) shares are tumbling after Deutsche Bank<a href=\"http://wallstcheatsheet.com/stocks/analysts-pier-1-imports-projected-to-hold-up-well-and-3-other-research-notes-to-peruse.html/4/\" target=\"_blank\"> downgraded</a> the stock to Sell from Hold and lowered its PT to $24 from $32. Deutsche believes the company's reported margin improvement stems from aggressive accounting.</li></ul><div class=\"tiny-share-widget\" data-id=\"1258082\" data-linked=\"CGI Group tumbles on Deutsche downgrade\" data-tweet=\"$GIB - CGI Group tumbles on Deutsche downgrade https://seekingalpha.com/news/1258082-cgi-group-tumbles-on-deutsche-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/1258082-cgi-group-tumbles-on-deutsche-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1258042\" data-ts=\"1378237228\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MYL\" target=\"_blank\">MYL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1258042-mylan-gets-the-thumbs-up-from-indias-foreign-investment-promotion-board-for-its-acquisition-of-agila-injectables\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mylan gets the thumbs up from India&#39;s Foreign Investment Promotion Board for its acquisition of Agila Injectables</a></h4><ul>\n<li>Mylan (<a href=\"https://seekingalpha.com/symbol/MYL\" title=\"Mylan Inc\">MYL</a> <font color=\"green\">+1.3%</font>) says its proposed acquisition of the Agila injectables businesses from Strides Arcolab has received approval from India's Foreign Investment Promotion Board.</li>\n<li>The deal also received approval from the Cabinet Committee on Economic Affairs.</li>\n<li>The approval comes as a relief for <a href=\"https://seekingalpha.com/symbol/MYL\" title=\"Mylan Inc\">MYL</a>, as India had <a href=\"https://seekingalpha.com/market_currents/post/1125672\" target=\"_blank\">frozen the deal</a> earlier this year, and was considering a change to its foreign investment laws to protect the country's supply of cheap, lifesaving drugs.</li>\n<li>The transaction is expected to close in Q4.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1258042\" data-linked=\"Mylan gets the thumbs up from India&#39;s Foreign Investment Promotion Board for its acquisition of Agila Injectables\" data-tweet=\"$MYL - Mylan gets the thumbs up from India&#39;s Foreign Investment Promotion Board for its acquisition of Agila Injectables https://seekingalpha.com/news/1258042-mylan-gets-the-thumbs-up-from-indias-foreign-investment-promotion-board-for-its-acquisition-of-agila-injectables?source=tweet\" data-url=\"https://seekingalpha.com/news/1258042-mylan-gets-the-thumbs-up-from-indias-foreign-investment-promotion-board-for-its-acquisition-of-agila-injectables\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1258022\" data-ts=\"1378236791\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCX\" target=\"_blank\">FCX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1258022-freeport-indonesia-lifts-force-majeure-at-grasberg-copper-mine\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Freeport Indonesia lifts force majeure at Grasberg copper mine</a></h4><ul>\n<li>The Indonesian unit of Freeport-McMoRan (<a href=\"https://seekingalpha.com/symbol/FCX\" title=\"Freeport-McMoRan Inc.\">FCX</a> <font color=\"green\">+3.1%</font>) has <a href=\"http://www.reuters.com/article/2013/09/03/indonesia-freeport-forcemajeure-idUSJ9N09F02120130903\" target=\"_blank\">lifted its force majeure</a> at the Grasberg mine, the world's second-biggest copper mine, almost four months after a deadly accident <a href=\"https://seekingalpha.com/currents/search?query=freeport+grasberg\" target=\"_blank\">forced a halt in operations</a>, the local CEO says.</li>\n<li>Copper prices are <a href=\"http://online.wsj.com/article/SB10001424127887323932604579053250899504342.html\" target=\"_blank\">rallying</a> today, up 2.2%, fueled by a trifecta of stronger manufacturing data from China, Europe and the U.S.</li>\n<li>Copper prices have been trending upward since June, but Paul Ausick notes production is estimated to be 167K metric tons above demand this year and rising to 408K metric tons of excess production next year, which makes virtually certain a drop in price with <a href=\"http://247wallst.com/commodities-metals/2013/09/03/copper-production-price-point-in-opposite-directions/\" target=\"_blank\">the only question the size of the drop</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1258022\" data-linked=\"Freeport Indonesia lifts force majeure at Grasberg copper mine\" data-tweet=\"$FCX - Freeport Indonesia lifts force majeure at Grasberg copper mine https://seekingalpha.com/news/1258022-freeport-indonesia-lifts-force-majeure-at-grasberg-copper-mine?source=tweet\" data-url=\"https://seekingalpha.com/news/1258022-freeport-indonesia-lifts-force-majeure-at-grasberg-copper-mine\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1257962\" data-ts=\"1378235479\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCRX\" target=\"_blank\">OCRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1257962-ocera-therapeutics-names-a-new-cfo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ocera Therapeutics names a new CFO</a></h4><ul>\n<li>Ocera Therapeutics (<a href=\"https://seekingalpha.com/symbol/OCRX\" title=\"Ocera Therapeutics, Inc.\">OCRX</a> <font color=\"green\">+2.4%</font>) says <a href=\"http://www.streetinsider.com/Press+Releases/Jeryl+L.+Hilleman+Joins+Ocera+Therapeutics+as+Chief+Financial+Officer/8651855.html\" target=\"_blank\">it's appointed</a> Jeryl L. Hilleman as its new CFO, effective immediately.</li>\n<li>Hilleman replaces Dana McGowan, who will continue with the company during a transition period in which the company plans to move its headquarters to Northern California.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1257962\" data-linked=\"Ocera Therapeutics names a new CFO\" data-tweet=\"$OCRX - Ocera Therapeutics names a new CFO https://seekingalpha.com/news/1257962-ocera-therapeutics-names-a-new-cfo?source=tweet\" data-url=\"https://seekingalpha.com/news/1257962-ocera-therapeutics-names-a-new-cfo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1257922\" data-ts=\"1378234762\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OMED\" target=\"_blank\">OMED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1257922-oncomed-reports-its-first-quarterly-results-since-its-july-ipo-net-losses-widen\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OncoMed reports its first quarterly results since its July IPO; net losses widen</a></h4><ul>\n<li>OncoMed (<a href=\"https://seekingalpha.com/symbol/OMED\" title=\"OncoMed Pharmaceuticals, Inc\">OMED</a> <font color=\"green\">+1.5%</font>) moves up after reporting its first results since going public in July.</li>\n<li>\n<a href=\"https://seekingalpha.com/market_currents/post/1256462\" target=\"_blank\">Q2 net losses widened</a> to $9.6M from $3.8M for the year ago period, mainly because of the timing of a $5M milestone payment in the same quarter last year.</li>\n<li>Collaboration revenues declined to $2.9M, compared to $7.5M for Q212.</li>\n<li>The company received a $10M milestone payment in August, related to the Phase I dose escalation in its vantictumab program, part of its collaboration with Bayer Pharma AG.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1257922\" data-linked=\"OncoMed reports its first quarterly results since its July IPO; net losses widen\" data-tweet=\"$OMED - OncoMed reports its first quarterly results since its July IPO; net losses widen https://seekingalpha.com/news/1257922-oncomed-reports-its-first-quarterly-results-since-its-july-ipo-net-losses-widen?source=tweet\" data-url=\"https://seekingalpha.com/news/1257922-oncomed-reports-its-first-quarterly-results-since-its-july-ipo-net-losses-widen\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1257932\" data-ts=\"1378234744\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ESV\" target=\"_blank\">ESV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1257932-ensco-downgraded-at-barclays-on-concerns-over-operational-execution\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ensco downgraded at Barclays on concerns over operational execution</a></h4><ul>     <li>Ensco (<a href=\"https://seekingalpha.com/symbol/ESV\" title=\"Ensco PLC\">ESV</a> <font color=\"red\">-2.1%</font>) is <a href=\"http://www.stockviews.com/stock?s=ESV\" target=\"_blank\">downgraded</a> to Equal Weight from Overweight with a $60 price target (from $82) at Barclays, which sees continued high levels of unplanned downtime prompting concerns with ESV's operational execution, despite its high-quality mixed fleet of relatively standardized assets.</li>     <li>The firm prefers ultra-deepwater pure-plays, including Ocean Rig (<a href=\"https://seekingalpha.com/symbol/ORIG\" title=\"Ocean Rig UDW Inc.\">ORIG</a> <font color=\"green\">+2.1%</font>) and Pacific Drilling (<a href=\"https://seekingalpha.com/symbol/PACD\" title=\"Pacific Drilling SA\">PACD</a> <font color=\"green\">+2.6%</font>), and catalyst-rich offshore drillers led by Noble Corp. (<a href=\"https://seekingalpha.com/symbol/NE\" title=\"Noble Corporation plc\">NE</a> <font color=\"red\">-0.4%</font>), which is undergoing operational improvements and is moving forward with a meaningful non-core asset divestiture.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1257932\" data-linked=\"Ensco downgraded at Barclays on concerns over operational execution\" data-tweet=\"$ESV $VAL $ORIG - Ensco downgraded at Barclays on concerns over operational execution https://seekingalpha.com/news/1257932-ensco-downgraded-at-barclays-on-concerns-over-operational-execution?source=tweet\" data-url=\"https://seekingalpha.com/news/1257932-ensco-downgraded-at-barclays-on-concerns-over-operational-execution\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1257912\" data-ts=\"1378234371\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CCE-OLD\" target=\"_blank\">CCE-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1257912-coca-cola-enterprises-upgraded-to-conviction-buy-at-goldman\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coca-Cola Enterprises upgraded to Conviction Buy at Goldman</a></h4><ul>\n<li>Coca-Cola Enterprises (<a href=\"https://seekingalpha.com/symbol/CCE-OLD\" title=\"Coca-Cola European Partners plc\">CCE-OLD</a> <font color=\"green\">+2.3%</font>) gets a lift from Goldman's Judy Hong who <a href=\"http://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Upgrades+Coca-Cola+Enterprises+%28CCE%29+to+Conviction+Buy/8652072.html\" target=\"_blank\">upgrades the shares</a> to Conviction Buy from Neutral.</li>\n<li>The risk/ reward looks good, Hong thinks, as the fundamentals are improving and the valuation \u2014 at 14x forward earnings \u2014 is very reasonable.</li>\n<li>FY14 and FY15 EPS estimates raised to $2.91 (from $2.87) and $3.47 (from $3.46) respectively.</li>\n<li>Price target hiked to $47 from $43.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1257912\" data-linked=\"Coca-Cola Enterprises upgraded to Conviction Buy at Goldman\" data-tweet=\"$CCE-OLD $CCEP - Coca-Cola Enterprises upgraded to Conviction Buy at Goldman https://seekingalpha.com/news/1257912-coca-cola-enterprises-upgraded-to-conviction-buy-at-goldman?source=tweet\" data-url=\"https://seekingalpha.com/news/1257912-coca-cola-enterprises-upgraded-to-conviction-buy-at-goldman\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1257892\" data-ts=\"1378234263\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KODK\" target=\"_blank\">KODK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1257892-kodak-emerges-from-chapter-11\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kodak emerges from Chapter 11</a></h4><ul>\n<li>Two weeks after a bankruptcy judge <a href=\"https://seekingalpha.com/currents/post/1233952\" target=\"_blank\">signed off</a> on Eastman Kodak's (EKDKQ.PK <font color=\"red\">-45.6%</font>) restructuring plan, the company has officially emerged from Chap. 11. (PR) (<a href=\"http://biz.yahoo.com/e/130903/ekdkq8-k.html\" target=\"_blank\">8-K</a>)</li>\n<li>The emergence follows the sale of Kodak's personalized/document imaging ops to its pension plan, the completion of a rights offering, and the sale of $406M in new equity to unsecured creditors, among other moves.</li>\n<li>All previously issued and outstanding Kodak shares have been cancelled, along with all other prior equity interests. Initial distributions related to \"general unsecured claims\" are due by the end of September.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1257892\" data-linked=\"Kodak emerges from Chapter 11\" data-tweet=\"$KODK - Kodak emerges from Chapter 11 https://seekingalpha.com/news/1257892-kodak-emerges-from-chapter-11?source=tweet\" data-url=\"https://seekingalpha.com/news/1257892-kodak-emerges-from-chapter-11\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:51 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1257882\" data-ts=\"1378234222\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENPH\" target=\"_blank\">ENPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1257882-enphase-paring-gains-after-roth-capital-initiation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Enphase paring gains after Roth Capital initiation</a></h4><ul><li>Shares of Enphase Energy (<a href='https://seekingalpha.com/symbol/ENPH' title='Enphase Energy Inc.'>ENPH</a> <font color='green'>+4%</font>) are paring gains that saw them up as much as 8.6% earlier in the day. The climb came after Roth Capital initiated the stock at Buy with a PT of $10.</li><li>Analyst Philip Shen <a href=\"http://finance.yahoo.com/news/enphase-energy-shares-rise-buy-181050689.html\" target=\"_blank\">believes </a>Enphase is \"years ahead of competitors on the technology front,\"because it updates its microinverters every 2 years as opposed to more sluggish peers. He also pinpointed Enphase's international expansion as a growth driver.</li></ul><div class=\"tiny-share-widget\" data-id=\"1257882\" data-linked=\"Enphase paring gains after Roth Capital initiation\" data-tweet=\"$ENPH - Enphase paring gains after Roth Capital initiation https://seekingalpha.com/news/1257882-enphase-paring-gains-after-roth-capital-initiation?source=tweet\" data-url=\"https://seekingalpha.com/news/1257882-enphase-paring-gains-after-roth-capital-initiation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1257872\" data-ts=\"1378233729\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UPI\" target=\"_blank\">UPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1257872-class-action-lawsuit-against-uroplasty-dismissed\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Class action lawsuit against Uroplasty dismissed</a></h4><ul><li>Uroplasty (<a href=\"https://seekingalpha.com/symbol/UPI\" title=\"Uroplasty, Inc\">UPI</a> <font color=\"green\">+4.8%</font>) says a class action lawsuits filed against the company alleging possible violations of federal securities laws in relation to the delayed filing of its 10K earlier this year has been dismissed. No payment or consideration of any kind was made by <a href=\"https://seekingalpha.com/symbol/URI\" title=\"United Rentals, Inc.\">URI</a> in connection with these lawsuits.</li></ul><div class=\"tiny-share-widget\" data-id=\"1257872\" data-linked=\"Class action lawsuit against Uroplasty dismissed\" data-tweet=\"$UPI $UPI $URI - Class action lawsuit against Uroplasty dismissed https://seekingalpha.com/news/1257872-class-action-lawsuit-against-uroplasty-dismissed?source=tweet\" data-url=\"https://seekingalpha.com/news/1257872-class-action-lawsuit-against-uroplasty-dismissed\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1257862\" data-ts=\"1378233653\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIOS\" target=\"_blank\">BIOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1257862-bioscrip-plunges-on-insider-sales\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioScrip plunges on insider sales</a></h4><ul><li>Shares of BioScrip (<a href='https://seekingalpha.com/symbol/BIOS' title='BioScrip, Inc.'>BIOS</a> <font color='red'>-9.8%</font>) plunge after Finance VP Patricia Bogusz and Director David Huber disclosed the sale of <a href=\"http://www.insidermonkey.com/insider-trading/filing/4147033\" target=\"_blank\">40K shares </a>(3K remaining) and <a href=\"http://www.insidermonkey.com/insider-trading/filing/4147604\" target=\"_blank\">11K shares </a>(71K remaining) respectively over the weekend.</li></ul><div class=\"tiny-share-widget\" data-id=\"1257862\" data-linked=\"BioScrip plunges on insider sales\" data-tweet=\"$BIOS - BioScrip plunges on insider sales https://seekingalpha.com/news/1257862-bioscrip-plunges-on-insider-sales?source=tweet\" data-url=\"https://seekingalpha.com/news/1257862-bioscrip-plunges-on-insider-sales\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1257832\" data-ts=\"1378233412\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PACB\" target=\"_blank\">PACB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1257832-pacific-biosciences-trades-sharply-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pacific Biosciences trades sharply lower</a></h4><ul>     <li>Pacific Biosciences (<a href=\"https://seekingalpha.com/symbol/PACB\" title=\"Pacific Biosciences of California\">PACB</a> <font color=\"red\">-13.4%</font>) plunges on heavy volume with no obvious catalyst.</li>     <li>Investors could be taking profits after a <font color=\"green\">~59%</font> rally in August.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1257832\" data-linked=\"Pacific Biosciences trades sharply lower\" data-tweet=\"$PACB - Pacific Biosciences trades sharply lower https://seekingalpha.com/news/1257832-pacific-biosciences-trades-sharply-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/1257832-pacific-biosciences-trades-sharply-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1257812\" data-ts=\"1378232760\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLRX\" target=\"_blank\">BLRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1257812-biolinerx-to-present-at-rodman-and-renshaws-upcoming-global-investment-conference\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioLineRx to present at Rodman &amp; Renshaw&#39;s upcoming Global Investment Conference</a></h4><ul>\n<li>BioLineRx (<a href=\"https://seekingalpha.com/symbol/BLRX\" title=\"BioLineRx Ltd.\">BLRX</a> <font color=\"green\">+3.2%</font>) moves up after announcing that its CEO, Kinneret Savitsky, Ph.D., and its Chief Financial and Operating Officer, Philip Serlin, <a href=\"http://www.prnewswire.com/news-releases/biolinerx-to-present-at-15th-annual-rodman--renshaw-global-investment-conference-in-new-york-222148581.html\" target=\"_blank\">will be presenting</a> at the 15th Annual Rodman &amp; Renshaw Global Investment Conference in New York on  Tuesday, September 10.</li>\n<li>The presentation is scheduled to start at 11:40 a.m. EDT.</li>\n<li>A live audio webcast of the presentation will be available online at BioLineRx's investor web page, with an archive of the event also available.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1257812\" data-linked=\"BioLineRx to present at Rodman &amp; Renshaw&#39;s upcoming Global Investment Conference\" data-tweet=\"$BLRX - BioLineRx to present at Rodman &amp; Renshaw&#39;s upcoming Global Investment Conference https://seekingalpha.com/news/1257812-biolinerx-to-present-at-rodman-and-renshaws-upcoming-global-investment-conference?source=tweet\" data-url=\"https://seekingalpha.com/news/1257812-biolinerx-to-present-at-rodman-and-renshaws-upcoming-global-investment-conference\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:26 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1257802\" data-ts=\"1378232662\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVS\" target=\"_blank\">NVS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1257802-eu-approves-novartis-ilaris-for-sjia\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EU approves Novartis&#39; Ilaris for SJIA</a></h4><ul>\n<li>The European Union approves Novartis' (<a href=\"https://seekingalpha.com/symbol/NVS\" title=\"Novartis AG\">NVS</a> <font color=\"green\">+2.2%</font>) Ilaris for the treatment of <br>active systemic juvenile idiopathic arthritis in children 2 and up for whom NSAIDs and corticosteroids have proved inadequate. <br>\n</li>\n<li>\"The EU approval of Ilaris provides patients suffering from SJIA with a  convenient new treatment option offering a favorable benefit-risk  profile, administered as a single monthly subcutaneous injection,\" a Novartis official says. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1257802\" data-linked=\"EU approves Novartis&#39; Ilaris for SJIA\" data-tweet=\"$NVS - EU approves Novartis&#39; Ilaris for SJIA https://seekingalpha.com/news/1257802-eu-approves-novartis-ilaris-for-sjia?source=tweet\" data-url=\"https://seekingalpha.com/news/1257802-eu-approves-novartis-ilaris-for-sjia\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1257792\" data-ts=\"1378232550\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1257792-gold-shakes-early-loss-to-surge-above-1400\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gold shakes early loss to surge above $1,400</a></h4><ul>     <li>Renewed beating of the <a href=\"https://seekingalpha.com/currents/post/1257172\" target=\"_blank\">war drums over Syria</a> has helped gold turn a 1% loss into a <font color=\"green\">1.3% gain</font>, the metal now fetching $1,414 per ounce. <a href=\"https://seekingalpha.com/symbol/gld\" title=\"SPDR Gold Trust ETF\">GLD</a><font color=\"green\"> +1.5%</font>.</li>     <li>Other gold ETFs: <a href=\"https://seekingalpha.com/symbol/iau\" title=\"iShares Gold Trust ETF\">IAU</a>, <a href=\"https://seekingalpha.com/symbol/sgol\" title=\"ETFS Physical Swiss Gold Trust ETF\">SGOL</a>, <a href=\"https://seekingalpha.com/symbol/phys\" title=\"Sprott Physical Gold Trust\">PHYS</a>, <a href=\"https://seekingalpha.com/symbol/agol\" title=\"ETFS Physical Asian Gold Shares Trust ETF\">AGOL</a>, <a href=\"https://seekingalpha.com/symbol/dgl\" title=\"PowerShares DB Gold ETF\">DGL</a>, <a href=\"https://seekingalpha.com/symbol/ubg\" title=\"UBS ETRACS CMCI Gold Total Return ETN\">UBG</a>, <a href=\"https://seekingalpha.com/symbol/dgp\" title=\"PowerShares DB Gold Double Long ETN\">DGP</a>, <a href=\"https://seekingalpha.com/symbol/ugl\" title=\"ProShares Ultra Gold ETF\">UGL</a>, <a href=\"https://seekingalpha.com/symbol/dzz\" title=\"PowerShares DB Gold Double Short ETN\">DZZ</a>, <a href=\"https://seekingalpha.com/symbol/gll\" title=\"ProShares UltraShort Gold ETF\">GLL</a>, <a href=\"https://seekingalpha.com/symbol/dgz\" title=\"PowerShares DB Gold Short ETN\">DGZ</a>, <a href=\"https://seekingalpha.com/symbol/ugld\" title=\"VelocityShares 3x Long Gold ETN\">UGLD</a>, <a href=\"https://seekingalpha.com/symbol/dgld\" title=\"VelocityShares 3x Inverse Gold ETN\">DGLD</a>, <a href=\"https://seekingalpha.com/symbol/gldi\" title=\"Credit Suisse Gold Shares Covered Call ETN\">GLDI</a>.</li>     <li>WTI crude has also turned around, now <font color=\"green\">0.8% higher</font> at $108.51 per barrel. <a href=\"https://seekingalpha.com/symbol/uso\" title=\"The United States Oil ETF, LP\">USO</a> <font color=\"green\">+0.7%</font>.</li>     <li>Other oil ETFs: <a href=\"https://seekingalpha.com/symbol/oil\" title=\"iPath S&amp;P Crude Oil Total Return Index ETN\">OIL</a>, <a href=\"https://seekingalpha.com/symbol/dbo\" title=\"PowerShares DB Oil ETF\">DBO</a>, <a href=\"https://seekingalpha.com/symbol/olo\" title=\"PowerShares DB Crude Oil Long ETN\">OLO</a>, <a href=\"https://seekingalpha.com/symbol/usl\" title=\"The United States 12 Month Oil ETF, LP\">USL</a>, <a href=\"https://seekingalpha.com/symbol/crud\" title=\"Teucrium WTI Crude Oil ETF\">CRUD</a>, <a href=\"https://seekingalpha.com/symbol/uco\" title=\"ProShares Ultra DJ-UBS Crude Oil ETF\">UCO</a>, <a href=\"https://seekingalpha.com/symbol/dto\" title=\"PowerShares DB Crude Oil Double Short ETN\">DTO</a>, <a href=\"https://seekingalpha.com/symbol/sco\" title=\"ProShares UltraShort DJ-UBS Crude Oil ETF\">SCO</a>, <a href=\"https://seekingalpha.com/symbol/szo\" title=\"PowerShares DB Crude Oil Short ETN\">SZO</a>, <a href=\"https://seekingalpha.com/symbol/dno\" title=\"The United States Short Oil ETF, LP\">DNO</a>, <a href=\"https://seekingalpha.com/symbol/uwti\" title=\"VelocityShares 3x Long Crude Oil ETN\">UWTI</a>, <a href=\"https://seekingalpha.com/symbol/dwti\" title=\"VelocityShares 3x Inverse Crude Oil ETN\">DWTI</a>, <a href=\"https://seekingalpha.com/symbol/bno\" title=\"The United States Brent Oil ETF, LP\">BNO</a>, <a href=\"https://seekingalpha.com/symbol/uoil\" title=\"VelocityShares 3x Long Brent Crude ETN\">UOIL</a>, <a href=\"https://seekingalpha.com/symbol/doil\" title=\"VelocityShares 3x Inverse Brent Crude ETN\">DOIL</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1257792\" data-linked=\"Gold shakes early loss to surge above $1,400\" data-tweet=\"$GLD $IAU $SGOL - Gold shakes early loss to surge above $1,400 https://seekingalpha.com/news/1257792-gold-shakes-early-loss-to-surge-above-1400?source=tweet\" data-url=\"https://seekingalpha.com/news/1257792-gold-shakes-early-loss-to-surge-above-1400\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1257772\" data-ts=\"1378232414\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLS\" target=\"_blank\">SLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1257772-galena-biopharma-launches-a-cancer-patient-registry-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Galena Biopharma launches a cancer patient registry study</a></h4><p>Galena Biopharma (GALE <font color=\"green\">+3%</font>) gains today after saying it's started a cancer patient registry study to be known as RELIEF: Rapid Evaluation of Lifestyle, Independence, and Elimination of breakthrough cancer pain with Freedom from oral discomfort through the use of Abstral Sublingual Tablets. RELIEF is a post-marketing multi-center trial to assess its Abstral medication for breakthrough cancer pain in opioid-tolerant cancer patients.</p><div class=\"tiny-share-widget\" data-id=\"1257772\" data-linked=\"Galena Biopharma launches a cancer patient registry study\" data-tweet=\"$SLS - Galena Biopharma launches a cancer patient registry study https://seekingalpha.com/news/1257772-galena-biopharma-launches-a-cancer-patient-registry-study?source=tweet\" data-url=\"https://seekingalpha.com/news/1257772-galena-biopharma-launches-a-cancer-patient-registry-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1257702\" data-ts=\"1378231197\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTPH\" target=\"_blank\">TTPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1257702-tetraphase-pharmaceuticals-doses-its-first-patient-in-phase-iii-trials-of-eravacycline\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tetraphase Pharmaceuticals doses its first patient in Phase III trials of Eravacycline</a></h4><ul><li>Tetraphase Pharmaceuticals (<a href='https://seekingalpha.com/symbol/TTPH' title='Tetraphase Pharmaceuticals'>TTPH</a> <font color='green'>+3.4%</font>) gains after saying it's <a href=\"http://www.businesswire.com/news/home/20130903005455/en/Tetraphase-Doses-Patient-Phase-3-Clinical-Trial\" target=\"_blank\">first patient was dosed</a> in Phase III testing of its Eravacycline drug candidate for the treatment of complicated intra-abdominal infections.</li><li>The company is also planning for a late-stage trial using the drug in complicated urinary tract infections.</li></ul><div class=\"tiny-share-widget\" data-id=\"1257702\" data-linked=\"Tetraphase Pharmaceuticals doses its first patient in Phase III trials of Eravacycline\" data-tweet=\"$TTPH - Tetraphase Pharmaceuticals doses its first patient in Phase III trials of Eravacycline https://seekingalpha.com/news/1257702-tetraphase-pharmaceuticals-doses-its-first-patient-in-phase-iii-trials-of-eravacycline?source=tweet\" data-url=\"https://seekingalpha.com/news/1257702-tetraphase-pharmaceuticals-doses-its-first-patient-in-phase-iii-trials-of-eravacycline\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1257542\" data-ts=\"1378230269\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STXS\" target=\"_blank\">STXS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1257542-stereotaxis-renews-its-revolving-credit-facility\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stereotaxis renews its revolving credit facility</a></h4><ul>\n<li>Stereotaxis (<a href=\"https://seekingalpha.com/symbol/STXS\" title=\"Stereotaxis, Inc.\">STXS</a> <font color=\"green\">+8.3%</font>) gains after saying <a href=\"http://www.streetinsider.com/Corporate+News/Stereotaxis+%28STXS%29+Completes+Revolving+Facility+Renewal+with+SVB/8653240.html\" target=\"_blank\">it's renewed</a> a $3M revolving credit facility with Silicon Valley Bank to extend through March 31, 2014.</li>\n<li>The healthcare technology company said the prepayment premium was eliminated from the agreement, allowing it to repay the outstanding amount under the existing facility before its maturity date of December 2013, without penalty.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1257542\" data-linked=\"Stereotaxis renews its revolving credit facility\" data-tweet=\"$STXS - Stereotaxis renews its revolving credit facility https://seekingalpha.com/news/1257542-stereotaxis-renews-its-revolving-credit-facility?source=tweet\" data-url=\"https://seekingalpha.com/news/1257542-stereotaxis-renews-its-revolving-credit-facility\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1257502\" data-ts=\"1378229160\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IONS\" target=\"_blank\">IONS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1257502-isis-pharmaceuticals-moves-up-on-positive-data-from-phase-ii-studies-of-its-triglyceride-treatment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Isis Pharmaceuticals moves up on positive data from Phase II studies of its triglyceride treatment</a></h4><ul><li>Isis Pharmaceuticals (ISIS <font color='red'>-2.8%</font>) moves up after announcing yesterday that <a href=\"https://seekingalpha.com/market_currents/post/1255672\" target=\"_blank\">interim data</a> from its ongoing Phase II study of ISIS-APOCIIIRx reduces blood fat.</li><li>ISIS-APOCIIIRx a monotherapy that reduces triglycerides in patients whose levels are severely high.</li></ul><div class=\"tiny-share-widget\" data-id=\"1257502\" data-linked=\"Isis Pharmaceuticals moves up on positive data from Phase II studies of its triglyceride treatment\" data-tweet=\"$IONS - Isis Pharmaceuticals moves up on positive data from Phase II studies of its triglyceride treatment https://seekingalpha.com/news/1257502-isis-pharmaceuticals-moves-up-on-positive-data-from-phase-ii-studies-of-its-triglyceride-treatment?source=tweet\" data-url=\"https://seekingalpha.com/news/1257502-isis-pharmaceuticals-moves-up-on-positive-data-from-phase-ii-studies-of-its-triglyceride-treatment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:26 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1257492\" data-ts=\"1378228682\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFUN\" target=\"_blank\">SFUN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1257492-soufun-climbs-on-surging-housing-prices-in-china\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SouFun climbs on surging housing prices in China</a></h4><ul>     <li>SouFun (<a href=\"https://seekingalpha.com/symbol/SFUN\" title=\"Fang Holdings Ltd. ADS\">SFUN</a> <font color=\"green\">+10%</font>) shares continue to run after the company <a href=\"http://www.bloomberg.com/news/2013-09-02/china-s-august-home-prices-rise-amid-land-sales-soufun-says.html\" target=\"_blank\">reported </a>that Chinese home prices surged 8.6% Y/Y in Aug., the largest leap since last Dec.</li>     <li>The market is expected to continue to be white hot, after buyers have seen  \"a series of land sold at record prices, while the government didn't take much action,\" according to Mizuho's Alan Jin.</li>     <li>The stock has run <font color=\"green\">up 83.8%</font> YTD, but its valuation still \"look[s] reasonable,\" <a href=\"http://blogs.barrons.com/emergingmarketsdaily/2013/09/03/china-august-home-price-jumped-soufun-advances-valuation-still-reasonable/?mod=yahoobarrons\" target=\"_blank\">opines</a><em> Barron's.</em>\n</li>     <li>\n<a href=\"https://seekingalpha.com/currents/post/1230162\" target=\"_blank\">Previous</a>: Soufun jumps on Chinese real estate market strength</li> </ul><div class=\"tiny-share-widget\" data-id=\"1257492\" data-linked=\"SouFun climbs on surging housing prices in China\" data-tweet=\"$SFUN - SouFun climbs on surging housing prices in China https://seekingalpha.com/news/1257492-soufun-climbs-on-surging-housing-prices-in-china?source=tweet\" data-url=\"https://seekingalpha.com/news/1257492-soufun-climbs-on-surging-housing-prices-in-china\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1257402\" data-ts=\"1378226762\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRAN\" target=\"_blank\">PRAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1257402-prana-biotechnologys-huntingtons-and-alzheimers-treatment-touted-as-drug-to-watch-by-elsevier-business-intelligence\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Prana Biotechnology&#39;s Huntington&#39;s and Alzheimer&#39;s treatment touted as drug to watch by Elsevier Business Intelligence</a></h4><ul>\n<li>Prana Biotechnology (<a href=\"https://seekingalpha.com/symbol/PRAN\" title=\"Prana Biotechnology Ltd\">PRAN</a> <font color=\"green\">+9.5%</font>) moves up after after Elsevier Business Intelligence <a href=\"http://www.4-traders.com/PRANA-BIOTECHNOLOGY-LIMIT-10352933/news/Prana-Biotechnology-Limited--Prana-Drug-Treatment-PBT2-Named-One-of-Top-Neuroscience-Projects-to-Wa-17233728/\" target=\"_blank\">touted its PBT2 drug candidate</a> to treat Huntington's and Alzheimer's among the top 10 neuroscience projects to watch.</li>\n<li>The top 10 list is selected by an independent panel each year to highlight compounds addressing a large, unmet market, strong science and a diversity of indications.</li>\n<li>Other criteria include the potential for new opportunities beyond initial indications, multi-level partnering opportunities and a strong company behind the compound.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/PRAN\" title=\"Prana Biotechnology Ltd\">PRAN</a> is expected to release results on PBT2 in October 2013.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1257402\" data-linked=\"Prana Biotechnology&#39;s Huntington&#39;s and Alzheimer&#39;s treatment touted as drug to watch by Elsevier Business Intelligence\" data-tweet=\"$PRAN $ATHE - Prana Biotechnology&#39;s Huntington&#39;s and Alzheimer&#39;s treatment touted as drug to watch by Elsevier Business Intelligence https://seekingalpha.com/news/1257402-prana-biotechnologys-huntingtons-and-alzheimers-treatment-touted-as-drug-to-watch-by-elsevier-business-intelligence?source=tweet\" data-url=\"https://seekingalpha.com/news/1257402-prana-biotechnologys-huntingtons-and-alzheimers-treatment-touted-as-drug-to-watch-by-elsevier-business-intelligence\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1257412\" data-ts=\"1378226762\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1257412-midday-top-10-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday top 10 gainers / Losers</a></h4><ul>     <li>\n<b>Midday top 10 gainers:</b> <a href=\"https://seekingalpha.com/symbol/NOK\" title=\"Nokia Corporation\">NOK</a> <font color=\"green\">+29%</font>. <a href=\"https://seekingalpha.com/symbol/PSTR\" title=\"PostRock Energy Corporation\">OTC:PSTR</a> <font color=\"green\">+12%</font>. <a href=\"https://seekingalpha.com/symbol/PRAN\" title=\"Prana Biotechnology Ltd\">PRAN</a> <font color=\"green\">+10%</font>. ALU <font color=\"green\">+10%</font>. <a href=\"https://seekingalpha.com/symbol/TWER-OLD\" title=\"Towerstream Corporation\">TWER</a> <font color=\"green\">+10%</font>. <a href=\"https://seekingalpha.com/symbol/INFN\" title=\"Infinera Corporation\">INFN</a> <font color=\"green\">+10%</font>. <a href=\"https://seekingalpha.com/symbol/SFUN\" title=\"Fang Holdings Ltd. ADS\">SFUN</a> <font color=\"green\">+10%</font>. <a href=\"https://seekingalpha.com/symbol/STSA\" title=\"Sterling Financial Corporation\">STSA</a> <font color=\"green\">+9%</font>. HSOL <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/CNIT-OLD\" title=\"China Information Technology\">CNIT-OLD</a> <font color=\"green\">+9%</font>.</li>\n<li>\n<b>Midday top 10 Losers:</b> <a href=\"https://seekingalpha.com/symbol/CYTK\" title=\"Cytokinetics, Incorporated\">CYTK</a> <font color=\"red\">-24%</font>. <a href=\"https://seekingalpha.com/symbol/PLCC\" title=\"Paulson Capital Corp.\">PLCC</a> <font color=\"red\">-13%</font>. <a href=\"https://seekingalpha.com/symbol/CTC\" title=\"IFM Investments Limited\">CTC</a> <font color=\"red\">-12%</font>. <a href=\"https://seekingalpha.com/symbol/MUR\" title=\"Murphy Oil Corporation\">MUR</a> <font color=\"red\">-12%</font>. <a href=\"https://seekingalpha.com/symbol/BIOS\" title=\"BioScrip, Inc.\">BIOS</a> <font color=\"red\">-10%</font>. CADX <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/DAEG\" title=\"Daegis\">DAEG</a> <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/PACB\" title=\"Pacific Biosciences of California\">PACB</a> <font color=\"red\">-8%</font>. <a href=\"https://seekingalpha.com/symbol/ARQL\" title=\"ArQule, Inc.\">ARQL</a> <font color=\"red\">-8%</font>. <a href=\"https://seekingalpha.com/symbol/SHIP\" title=\"Seanergy Maritime Holdings Corp\">SHIP</a> <font color=\"red\">-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1257412\" data-linked=\"Midday top 10 gainers / Losers\" data-tweet=\"$NOK $PSTR $ATHE - Midday top 10 gainers / Losers https://seekingalpha.com/news/1257412-midday-top-10-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1257412-midday-top-10-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1257372\" data-ts=\"1378225930\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EPRS\" target=\"_blank\">EPRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1257372-zalicus-completes-enrollment-for-two-phase-ii-studies-of-its-neuropathic-pain-treatment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zalicus completes enrollment for two Phase II studies of its neuropathic pain treatment</a></h4><ul>\n<li>Zalicus (ZLCS <font color=\"green\">+10.7%</font>) says it's completed patient enrollment in two Phase II clinical studies of Z160, an oral, state-dependent, selective N-type calcium channel blocker in development for chronic neuropathic pain, including lumbosacral radiculopathy and postherpetic neuralgia.</li>\n<li>Top-line results of both studies are expected in Q4.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1257372\" data-linked=\"Zalicus completes enrollment for two Phase II studies of its neuropathic pain treatment\" data-tweet=\"$EPRS - Zalicus completes enrollment for two Phase II studies of its neuropathic pain treatment https://seekingalpha.com/news/1257372-zalicus-completes-enrollment-for-two-phase-ii-studies-of-its-neuropathic-pain-treatment?source=tweet\" data-url=\"https://seekingalpha.com/news/1257372-zalicus-completes-enrollment-for-two-phase-ii-studies-of-its-neuropathic-pain-treatment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1257322\" data-ts=\"1378225542\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VLO\" target=\"_blank\">VLO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1257322-kinder-morgan-valero-place-parkway-pipeline-into-service\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kinder Morgan, Valero place Parkway Pipeline into service</a></h4><ul>     <li>Valero Energy (<a href=\"https://seekingalpha.com/symbol/VLO\" title=\"Valero Energy Corporation\">VLO</a> <font color=\"green\">+2.1%</font>) and Kinder Morgan Partners (<a href=\"https://seekingalpha.com/symbol/KMP\" title=\"Kinder Morgan Energy Partners L.P\">KMP</a> <font color=\"red\">-0.8%</font>; <a href=\"https://seekingalpha.com/symbol/KMI\" title=\"Kinder Morgan, Inc.\">KMI</a> <font color=\"red\">-0.8%</font>) say the Parkway Pipeline, a joint venture between the two companies, has been completed and is transporting refined crude products from refineries in Louisiana to a hub in Mississippi and from there to markets in the east coast.</li>     <li>The line has capacity to transport 110K bbl/day with ability to expand to more than 200K bbl/day.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1257322\" data-linked=\"Kinder Morgan, Valero place Parkway Pipeline into service\" data-tweet=\"$VLO $VLO $KMP - Kinder Morgan, Valero place Parkway Pipeline into service https://seekingalpha.com/news/1257322-kinder-morgan-valero-place-parkway-pipeline-into-service?source=tweet\" data-url=\"https://seekingalpha.com/news/1257322-kinder-morgan-valero-place-parkway-pipeline-into-service\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1257312\" data-ts=\"1378225072\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARR\" target=\"_blank\">ARR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1257312-mortgage-reits-hammered-as-rates-jump\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mortgage REITs hammered as rates jump</a></h4><ul>\n<li>Armour Residential (<a href=\"https://seekingalpha.com/symbol/ARR\" title=\"ARMOUR Residential REIT, Inc.\">ARR</a> <font color=\"red\">-2.9%</font>), CYS Investments (<a href=\"https://seekingalpha.com/symbol/CYS\" title=\"CYS Investments, Inc.\">CYS</a> <font color=\"red\">-2.3%</font>), and Hatteras Financial (<a href=\"https://seekingalpha.com/symbol/HTS\" title=\"Hatteras Financial Corp.\">HTS</a> <font color=\"red\">-2.5%</font>) are leading the mREIT sector (<a href=\"https://seekingalpha.com/symbol/REM\" title=\"iShares Mortgage Real Estate Capped ETF\">REM</a> <font color=\"red\">-1.3%</font>) lower as interest rates again <a href=\"https://seekingalpha.com/currents/post/1256922\" target=\"_blank\">move sharply higher</a>.</li>\n<li>Other movers include Annaly (<a href=\"https://seekingalpha.com/symbol/NLY\" title=\"Annaly Capital Management, Inc.\">NLY</a> <font color=\"red\">-1.6%</font>), Western Asset (<a href=\"https://seekingalpha.com/symbol/WMC\" title=\"Western Asset Mortgage Capital Corporation\">WMC</a> <font color=\"red\">-1.5%</font>), and Ellington (<a href=\"https://seekingalpha.com/symbol/EARN\" title=\"Ellington Residential Mortgage REIT\">EARN</a> <font color=\"red\">-2.2%</font>), (<a href=\"https://seekingalpha.com/symbol/EFC\" title=\"Ellington Financial LLC\">EFC</a> <font color=\"red\">-2.1%</font>).</li>\n<li>Other ETFs: <a href=\"https://seekingalpha.com/symbol/MORT\" title=\"VanEck Vectors Mortgage REIT Income ETF\">MORT</a>, <a href=\"https://seekingalpha.com/symbol/MORL\" title=\"UBS ETRACS Monthly Pay 2x Leveraged Mortgage REIT ETN\">MORL</a>.</li>\n<li>Still occasionally lumped in with mREITs, specialty mortgage servicers gain as the market now realizes the value of MSRs increases as rates move higher (fewer prepayments). Ocwen (<a href=\"https://seekingalpha.com/symbol/OCN\" title=\"Ocwen Financial Corporation\">OCN</a> <font color=\"green\">+4.1%</font>), Nationstar (<a href=\"https://seekingalpha.com/symbol/NSM\" title=\"Nationstar Mortgage Holdings\">NSM</a> <font color=\"green\">+2.4%</font>), Walter Investment (WAC <font color=\"green\">+1.8%</font>).</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1257312\" data-linked=\"Mortgage REITs hammered as rates jump\" data-tweet=\"$ARR $ARR $CYS - Mortgage REITs hammered as rates jump https://seekingalpha.com/news/1257312-mortgage-reits-hammered-as-rates-jump?source=tweet\" data-url=\"https://seekingalpha.com/news/1257312-mortgage-reits-hammered-as-rates-jump\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1257292\" data-ts=\"1378224944\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARQL\" target=\"_blank\">ARQL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1257292-arqule-says-its-received-a-letter-from-the-fda-recommending-lower-dosages-of-its-liver-cancer-treatment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ArQule says it&#39;s received a letter from the FDA recommending lower dosages of its liver cancer treatment</a></h4><ul>\n<li>ArQule (<a href=\"https://seekingalpha.com/symbol/ARQL\" title=\"ArQule, Inc.\">ARQL</a> <font color=\"red\">-7.2%</font>) slides after saying it's <a href=\"http://www.streetinsider.com/Corporate+News/ArQule+%28ARQL%29%2C+Daiichi+Sankyo+to+Conduct+Lower-Dose+Bvantinib+Phase+3/8652657.html\" target=\"_blank\">received a letter</a> from the FDA's Data Monitoring Committee, which is overseeing Phase III trials of its potential liver-cancer treatment, tivantinib, recommending reduced dosages due to a higher incidence of neutropenia than in earlier trials.</li>\n<li>The letter says the study dosage should be reduced from 240 milligrams twice daily to 120 milligrams, also saying the companies should revise its patient monitoring procedures to confirm the safety of the lower dose.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/ARQL\" title=\"ArQule, Inc.\">ARQL</a> is developing the drug jointly with Daiichi Sankyo.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1257292\" data-linked=\"ArQule says it&#39;s received a letter from the FDA recommending lower dosages of its liver cancer treatment\" data-tweet=\"$ARQL - ArQule says it&#39;s received a letter from the FDA recommending lower dosages of its liver cancer treatment https://seekingalpha.com/news/1257292-arqule-says-its-received-a-letter-from-the-fda-recommending-lower-dosages-of-its-liver-cancer-treatment?source=tweet\" data-url=\"https://seekingalpha.com/news/1257292-arqule-says-its-received-a-letter-from-the-fda-recommending-lower-dosages-of-its-liver-cancer-treatment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1257262\" data-ts=\"1378224327\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VHC\" target=\"_blank\">VHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1257262-virnetx-higher-after-announcing-3-new-patent-grants\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VirnetX higher after announcing 3 new patent grants</a></h4><ul>\n<li>The USPTO has granted VirnetX (<a href=\"https://seekingalpha.com/symbol/VHC\" title=\"VirnetX Holding Corporation\">VHC</a> <font color=\"green\">+2.9%</font>) 3 patents related to security features found in the 4G <a href=\"http://www.qualcomm.com/solutions/wireless-networks/technologies/lte-advanced\" target=\"_blank\">LTE-Advanced</a> standard (<a href=\"https://seekingalpha.com/currents/post/1116172\" target=\"_blank\">beginning</a> to be adopted by carriers). VirnetX calls the patents essential to LTE-Advanced, and has declared them as such to standards bodies. (PR)</li>\n<li>If the patents are recognized as standards-essential, that should open the door for them to be licensed to 4G hardware vendors under <a href=\"http://en.wikipedia.org/wiki/Reasonable_and_non-discriminatory_licensing\" target=\"_blank\">FRAND</a> terms.</li>\n<li>\n<a href=\"https://seekingalpha.com/currents/post/1255292\" target=\"_blank\">Previous:</a> Apple FaceTime workaround costs $2.4M/month</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1257262\" data-linked=\"VirnetX higher after announcing 3 new patent grants\" data-tweet=\"$VHC - VirnetX higher after announcing 3 new patent grants https://seekingalpha.com/news/1257262-virnetx-higher-after-announcing-3-new-patent-grants?source=tweet\" data-url=\"https://seekingalpha.com/news/1257262-virnetx-higher-after-announcing-3-new-patent-grants\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1257212\" data-ts=\"1378223514\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARAY\" target=\"_blank\">ARAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1257212-accuray-cfo-resigns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Accuray CFO resigns</a></h4><ul>\n<li>Accuray (<a href=\"https://seekingalpha.com/symbol/ARAY\" title=\"Accuray Incorporated\">ARAY</a> <font color=\"red\">-1.3%</font>) slips after announcing its CFO, Derek Bertocci, has resigned, effective immediately.</li>\n<li>It names Gregory Lichtwardt as his replacement.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1257212\" data-linked=\"Accuray CFO resigns\" data-tweet=\"$ARAY - Accuray CFO resigns https://seekingalpha.com/news/1257212-accuray-cfo-resigns?source=tweet\" data-url=\"https://seekingalpha.com/news/1257212-accuray-cfo-resigns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1257202\" data-ts=\"1378223395\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORIG\" target=\"_blank\">ORIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1257202-ocean-rig-inks-drillship-order-cowen-analysts-praise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ocean Rig inks drillship order, Cowen analysts praise</a></h4><ul>     <li>Ocean Rig (<a href=\"https://seekingalpha.com/symbol/ORIG\" title=\"Ocean Rig UDW Inc.\">ORIG</a> <font color=\"green\">+2%</font>) signs a contract to construct a seventh generation ultra-deepwater drillship at Samsung Heavy Industries in a project valued at ~$600M; delivery is scheduled for Dec. 2015.</li>     <li>The rig will be a sister ship to the three drillships currently under construction at Samsung, and will bring ORIG's UDW fleet to 11.</li>     <li>Assuming a $580K dayrate upon contract commencement, Cowen analysts estimate the rig \"will generate unlevered/levered returns of 16%/21%, still <a href=\"http://www.upstreamonline.com/live/article1336315.ece\" target=\"_blank\">very attractive economics</a> in a flattening dayrate environment.\"</li>     <li>ORIG also signs a supplemental agreement to amend certain provisions in its $1.35B senior secured facility dated Feb. 28, 2013.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1257202\" data-linked=\"Ocean Rig inks drillship order, Cowen analysts praise\" data-tweet=\"$ORIG - Ocean Rig inks drillship order, Cowen analysts praise https://seekingalpha.com/news/1257202-ocean-rig-inks-drillship-order-cowen-analysts-praise?source=tweet\" data-url=\"https://seekingalpha.com/news/1257202-ocean-rig-inks-drillship-order-cowen-analysts-praise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1257162\" data-ts=\"1378222393\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OIBR.C\" target=\"_blank\">OIBR.C</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1257162-oi-bounces-expands-lead-in-brazilian-wi-fi-market\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oi bounces; expands lead in Brazilian Wi-Fi market</a></h4><ul>\n<li>Oi (OIBR <font color=\"green\">+4.8%</font>) is bouncing after Brazil's telco regulator Anatel released <a href=\"http://www.teleco.com.br/wifi.asp\" target=\"_blank\">new statistics</a> on Wi-Fi hotspots in the country. Oi has expanded its lead considerably, offering 61.8K hotspots (91.5% of hotspots in the survey) as of Aug. The number represents a 232% increase from June. Net, in second place, offered only 3.5K hotspots in the same period.</li>\n<li>Last year, Oi VP of Marketing Marcos Ferraz Romero <a href=\"http://investors.ruckuswireless.com/phoenix.zhtml?c=251538&amp;p=irol-newsArticle&amp;ID=1754472&amp;highlight=\" target=\"_blank\">said</a>, \"There is a huge potential to increase penetration and integration of telecom services in Brazil, and we view Wi-Fi as a strategic technology accomplishing this.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1257162\" data-linked=\"Oi bounces; expands lead in Brazilian Wi-Fi market\" data-tweet=\"$OIBR.C - Oi bounces; expands lead in Brazilian Wi-Fi market https://seekingalpha.com/news/1257162-oi-bounces-expands-lead-in-brazilian-wi-fi-market?source=tweet\" data-url=\"https://seekingalpha.com/news/1257162-oi-bounces-expands-lead-in-brazilian-wi-fi-market\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1257152\" data-ts=\"1378222324\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPPI\" target=\"_blank\">SPPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1257152-spectrum-pharmaceuticals-ships-its-first-commercial-orders-for-marquibo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spectrum Pharmaceuticals ships its first commercial orders for Marquibo</a></h4><ul>\n<li>Spectrum Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/SPPI\" title=\"Spectrum Pharmaceuticals, Inc.\">SPPI</a> <font color=\"red\">-5%</font>) slides again today, despite saying it's shipped its first commercial orders for Marqibo, a phingomyelin/cholesterol liposome-encapsulated formulation of the FDA-approved anticancer drug vincristine.</li>\n<li>Marqibo ia approved for the treatment of Philadelphia chromosome-negative acute lymphoblastic leukemia in second or greater relapse or whose disease has progressed following two or more lines of anti-leukemia therapy.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1257152\" data-linked=\"Spectrum Pharmaceuticals ships its first commercial orders for Marquibo\" data-tweet=\"$SPPI - Spectrum Pharmaceuticals ships its first commercial orders for Marquibo https://seekingalpha.com/news/1257152-spectrum-pharmaceuticals-ships-its-first-commercial-orders-for-marquibo?source=tweet\" data-url=\"https://seekingalpha.com/news/1257152-spectrum-pharmaceuticals-ships-its-first-commercial-orders-for-marquibo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1257142\" data-ts=\"1378222311\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MUR\" target=\"_blank\">MUR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1257142-murphy-oil-completes-spinoff-of-retail-unit-shares-slide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Murphy Oil completes spinoff of retail unit, shares slide</a></h4><ul>     <li>Murphy Oil (<a href=\"https://seekingalpha.com/symbol/MUR\" title=\"Murphy Oil Corporation\">MUR</a> <font color=\"red\">-13%</font>) completes the spinoff of its U.S. retail marketing business into an independent public company, Murphy USA, which begins trading today on the NYSE under the ticker <a href=\"https://seekingalpha.com/symbol/MUSA\" title=\"Murphy USA, Inc.\">MUSA</a>.</li>     <li>To complete the spinoff, MUR shareholders received one common share of <a href=\"https://seekingalpha.com/symbol/MUSA\" title=\"Murphy USA, Inc.\">MUSA</a> for every four shares of MUR stock.</li>     <li>Andrew Clyde will be president and CEO of the new company, which will include more than 1,100 retail outlets, seven product distribution terminals and two ethanol production facilities in North Dakota and Texas.</li>     <li>Howard Weil <a href=\"http://www.streetinsider.com/Upgrades/Howard+Weil+Upgrades+Murphy+Oil+Corp.+%28MUR%29+to+Outperform/8652653.html\" target=\"_blank\">upgrades</a> shares to Outperform and raises its target to $76 from $69, seeing increased upside based on valuation versus peers and a new management team focused on stock price  appreciation.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1257142\" data-linked=\"Murphy Oil completes spinoff of retail unit, shares slide\" data-tweet=\"$MUR $MUR $MUSA - Murphy Oil completes spinoff of retail unit, shares slide https://seekingalpha.com/news/1257142-murphy-oil-completes-spinoff-of-retail-unit-shares-slide?source=tweet\" data-url=\"https://seekingalpha.com/news/1257142-murphy-oil-completes-spinoff-of-retail-unit-shares-slide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1257112\" data-ts=\"1378221186\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HLF\" target=\"_blank\">HLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1257112-herbalife-lower-after-wsj-article\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Herbalife lower after WSJ article</a></h4><ul>\n<li>Shares of Herbalife (<a href=\"https://seekingalpha.com/symbol/HLF\" title=\"Herbalife Ltd.\">HLF</a> <font color=\"red\">-3.8%</font>) are under a bit of pressure today, falling as much as 6% before recovering.</li>\n<li>Possibly behind the move is a <a href=\"http://online.wsj.com/article/SB10001424127887324324404579045083805583854.html\" target=\"_blank\"><em>WSJ</em> article</a> published late Friday online and in the Saturday print edition.</li>\n<li>The piece profiles Professor William Keep, the dean of the College of New Jersey's business school and the author (with FTC Senior Economist Peter Vander Nat) of the article \"<em>Marketing Fraud: An Approach for Differentiating Multilevel Marketing from Pyramid Schemes</em>\", a quote from which appears on Bill Ackman's factsaboutherbalife website.</li>\n<li>Keep has been consulted by two dozen investment firms in the past several months including Pershing Square, <em>WSJ</em> says. The professor was apparently questioned by the SEC this summer regarding his communications with Soros Fund, although it isn't clear why.</li>\n<li>Keep gives advice for free and although he has never opined on whether HLF is a pyramid scheme, he did say that the company \"lacks sufficient transparency for consumers and investors to make this critical assessment.\" HLF says \"for certain people, there will never be enough information.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1257112\" data-linked=\"Herbalife lower after WSJ article\" data-tweet=\"$HLF - Herbalife lower after WSJ article https://seekingalpha.com/news/1257112-herbalife-lower-after-wsj-article?source=tweet\" data-url=\"https://seekingalpha.com/news/1257112-herbalife-lower-after-wsj-article\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1257092\" data-ts=\"1378220851\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNST\" target=\"_blank\">MNST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1257092-monster-beverage-slips-with-rumors-popping-up-again\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Monster Beverage slips with rumors popping up again</a></h4><ul> <li>Monster Beverage (<a href='https://seekingalpha.com/symbol/MNST' title='Monster Beverage Corp.'>MNST</a> <font color='red'>-2.4%</font>) slips with <a href=\"https://twitter.com/zozotrader/status/374901519486701569\" target=\"_blank\">recycled rumors</a> that David Einhorn is short the stock cropping up.</li> <li>Volume spiked significantly higher during a 30-minute period mid-morning.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1257092\" data-linked=\"Monster Beverage slips with rumors popping up again\" data-tweet=\"$MNST - Monster Beverage slips with rumors popping up again https://seekingalpha.com/news/1257092-monster-beverage-slips-with-rumors-popping-up-again?source=tweet\" data-url=\"https://seekingalpha.com/news/1257092-monster-beverage-slips-with-rumors-popping-up-again\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1257032\" data-ts=\"1378220226\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FNF\" target=\"_blank\">FNF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1257032-title-insurers-boosted-at-kbw\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Title insurers boosted at KBW</a></h4><ul>\n<li>KBW's Bose George <a href=\"http://www.thestreet.com/story/12024490/1/buy-title-insurer-stocks-kbw.html\" target=\"_blank\">upgrades title insurers</a> Fidelity National Financial (<a href=\"https://seekingalpha.com/symbol/FNF\" title=\"Fidelity National Financial Inc.\">FNF</a> <font color=\"green\">+3.5%</font>) and First American Financial (<a href=\"https://seekingalpha.com/symbol/FAF\" title=\"First American Financial Corporation\">FAF</a> <font color=\"green\">+2.6%</font>) to Buy, telling clients his team is changing its valuation approach for a greater focus on longer-term earnings.</li>\n<li>The sector (FNF and FAF control about 2/3 of U.S. title insurance volume) has underperformed this year on concern about slowing refinance volume, but George expects the market to look past the valley and see strong earnings growth in 2015 and beyond as the home purchase market continues its recovery.</li>\n<li>He notes MBA mortgage data - slowing big-time of late - understates purchase activity as it does not track cash sales which happen to a fast-growing segment of total activity.</li>\n<li>The price target for FNF is hiked to $31 from $27, in part as George boosts his 2014 EPS estimate to $1.85 from $1.66 thanks to the acquisition of Lender Processing Services (NYSE:<a href=\"https://seekingalpha.com/symbol/LPS\" title=\"Lender Processing Services, Inc.\">LPS</a>) - expected to close in Q4.</li>\n<li>FAF's price target is unchanged at $28.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1257032\" data-linked=\"Title insurers boosted at KBW\" data-tweet=\"$FNF $FNF $FAF - Title insurers boosted at KBW https://seekingalpha.com/news/1257032-title-insurers-boosted-at-kbw?source=tweet\" data-url=\"https://seekingalpha.com/news/1257032-title-insurers-boosted-at-kbw\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1257022\" data-ts=\"1378220034\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCMP\" target=\"_blank\">SCMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1257022-sucampo-falls-on-maxim-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sucampo falls on Maxim downgrade</a></h4><ul>\n<li>Sucampo Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/SCMP\" title=\"Sucampo Pharmaceuticals, Inc.\">SCMP</a> <font color=\"red\">-7.8%</font>) is under pressure in early trading.</li>\n<li>Maxim <a href=\"http://www.benzinga.com/news/13/09/3882351/maxim-group-downgrades-sucampo-pharmaceuticals-inc-to-hold-lowers-pt-to-7-00\" target=\"_blank\">downgrades</a> the shares to Hold from Buy.</li>\n<li>Price target cut to $7 from $9.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1257022\" data-linked=\"Sucampo falls on Maxim downgrade\" data-tweet=\"$SCMP - Sucampo falls on Maxim downgrade https://seekingalpha.com/news/1257022-sucampo-falls-on-maxim-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/1257022-sucampo-falls-on-maxim-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:53 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1257012\" data-ts=\"1378220027\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GD\" target=\"_blank\">GD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1257012-general-dynamics-wins-a-56m-contract-support-extension-for-the-us-armys-m1a1-abrams-tank-in-iraq\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">General Dynamics wins a $56M contract support extension for the US Army&#39;s M1A1 Abrams tank in Iraq</a></h4><ul>\n<li>General Dynamics (<a href=\"https://seekingalpha.com/symbol/GD\" title=\"General Dynamics Corporation\">GD</a> <font color=\"green\">+1.7%</font>) gets a boost after saying it'a landed a $56M <a href=\"http://www.prnewswire.com/news-releases/us-army-awards-general-dynamics-56-million-for-logistic-support-222163121.html\" target=\"_blank\">contract extension</a> to provide ongoing logistics and base lifecycle support services in support of Iraqi M1A1 Abrams tanks.</li>\n<li>The work will be performed on site in Iraq by existing <a href=\"https://seekingalpha.com/symbol/GD\" title=\"General Dynamics Corporation\">GD</a> employees over the next 30 days.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1257012\" data-linked=\"General Dynamics wins a $56M contract support extension for the US Army&#39;s M1A1 Abrams tank in Iraq\" data-tweet=\"$GD - General Dynamics wins a $56M contract support extension for the US Army&#39;s M1A1 Abrams tank in Iraq https://seekingalpha.com/news/1257012-general-dynamics-wins-a-56m-contract-support-extension-for-the-us-armys-m1a1-abrams-tank-in-iraq?source=tweet\" data-url=\"https://seekingalpha.com/news/1257012-general-dynamics-wins-a-56m-contract-support-extension-for-the-us-armys-m1a1-abrams-tank-in-iraq\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:53 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1256992\" data-ts=\"1378219428\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HERO\" target=\"_blank\">HERO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1256992-hercules-offshore-secures-contract-for-newbuild-premium-rig\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hercules Offshore secures contract for newbuild premium rig</a></h4><ul>     <li>Hercules Offshore (<a href=\"https://seekingalpha.com/symbol/HERO\" title=\"Hercules Offshore Inc\">HERO</a> <font color=\"green\">+2.4%</font>) wins the first contract for its newbuild premium jack-up rig Hercules Triumph with Cairn India.</li>     <li>The 110-day contract is worth $36.6M, yielding a dayrate of ~$333K.</li>     <li>HERO says it is in discussions with several operators about follow-on work for the Triumph as well as work for the second in the harsh-environment class of rigs, which is expected to be delivered in Oct. 2013.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1256992\" data-linked=\"Hercules Offshore secures contract for newbuild premium rig\" data-tweet=\"$HERO $HEROQ - Hercules Offshore secures contract for newbuild premium rig https://seekingalpha.com/news/1256992-hercules-offshore-secures-contract-for-newbuild-premium-rig?source=tweet\" data-url=\"https://seekingalpha.com/news/1256992-hercules-offshore-secures-contract-for-newbuild-premium-rig\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1256962\" data-ts=\"1378218658\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1256962-blackberry-networking-stocks-surge-in-response-to-microsoft-nokia\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BlackBerry, networking stocks surge in response to Microsoft/Nokia</a></h4><ul>\n<li>BlackBerry (BBRY <font color=\"green\">+2.1%</font>) is rallying on hopes the <a href=\"https://seekingalpha.com/currents/post/1255792\" target=\"_blank\">Microsoft/Nokia blockbuster</a> will increase its chances of being acquired as it continues evaluating \"<a href=\"https://seekingalpha.com/currents/post/1214532\" target=\"_blank\">strategic alternatives</a>,\" and reportedly seeks out a \"<a href=\"https://seekingalpha.com/currents/post/1218372\" target=\"_blank\">Google-like</a>\" white knight.</li>\n<li>Deal optimism is overshadowing <a href=\"http://finance.yahoo.com/news/analysts-actions-nok-bbry-pfe-132000904.html\" target=\"_blank\">a bearish note</a> from Raymond James: the firm has cut estimates through 2015, and (backing up a recent <a href=\"https://seekingalpha.com/currents/post/1250752\" target=\"_blank\"><em>WSJ</em> column</a>) says checks indicate sell-through has been weak.</li>\n<li>Meanwhile, several smaller networking/telecom equipment makers have joined Alcatel-Lucent and Ericsson (<a href=\"https://seekingalpha.com/currents/post/1255922\" target=\"_blank\">previous</a>) in outperforming, as investors speculate Nokia will use some of its Microsoft cash to strengthen NSN via M&amp;A. Infinera (<a href=\"https://seekingalpha.com/symbol/INFN\" title=\"Infinera Corporation\">INFN</a> <font color=\"green\">+5.6%</font>), Ciena (<a href=\"https://seekingalpha.com/symbol/CIEN\" title=\"Ciena Corporation\">CIEN</a> <font color=\"green\">+3.5%</font>), DragonWave (<a href=\"https://seekingalpha.com/symbol/DRWI\" title=\"DragonWave Inc.\">DRWI</a> <font color=\"green\">+4.8%</font>), and Ruckus (<a href=\"https://seekingalpha.com/symbol/RKUS\" title=\"Ruckus Wireless\">RKUS</a> <font color=\"green\">+2.6%</font>) are among the winners.</li>\n<li>\n<a href=\"https://twitter.com/thenotablecalls/status/374889000294551553\" target=\"_blank\">Craig-Hallum</a> thinks Nokia is now likely to buy Ruckus, a leading player in carrier Wi-Fi and an existing <a href=\"http://nsn.com/news-events/press-room/press-releases/nokia-siemens-networks-signs-global-agreement-with-ruckus-wireless-to-resell-wi-fi-solutio\" target=\"_blank\">NSN partner</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1256962\" data-linked=\"BlackBerry, networking stocks surge in response to Microsoft/Nokia\" data-tweet=\"$BB $BB $INFN - BlackBerry, networking stocks surge in response to Microsoft/Nokia https://seekingalpha.com/news/1256962-blackberry-networking-stocks-surge-in-response-to-microsoft-nokia?source=tweet\" data-url=\"https://seekingalpha.com/news/1256962-blackberry-networking-stocks-surge-in-response-to-microsoft-nokia\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1256922\" data-ts=\"1378217643\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1256922-treasurys-slide-after-fast-ism-print\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Treasurys slide after fast ISM print</a></h4><ul>     <li>The 10-year Treasury yield shoots up to 2.88% following the <a href=\"https://seekingalpha.com/currents/post/1256862\" target=\"_blank\">fast ISM print</a> which will do little to slow momentum towards the QE taper. Expectations had been for a slowdown to 53.8, but instead the index sped up a hair to 55.7 - it's highest read of the year.</li>     <li>Leading the way were New Orders, which jumped 4.9 points to 63.2. Prices gained 5 points to 54.0. Supplier Deliveries edged higher to 52.3. Backlogs gained 1.5 points to 46.5. Production fell 2.6 points to 62.4. <a href=\"http://www.ism.ws/ISMReport/MfgROB.cfm?navItemNumber=12942\" target=\"_blank\">Full report here</a>.</li>     <li>\n<a href=\"https://seekingalpha.com/symbol/tlt\" title=\"iShares 20+ Year Treasury Bond ETF\">TLT</a> extends losses, now <font color=\"red\">off 1.7%</font>.</li>     <li>Treasury ETFs: <a href=\"https://seekingalpha.com/symbol/tlh\" title=\"iShares 10-20 Year Treasury Bond ETF\">TLH</a>, <a href=\"https://seekingalpha.com/symbol/tlt\" title=\"iShares 20+ Year Treasury Bond ETF\">TLT</a>, <a href=\"https://seekingalpha.com/symbol/ief\" title=\"iShares 7-10 Year Treasury Bond ETF\">IEF</a>, <a href=\"https://seekingalpha.com/symbol/dtyl\" title=\"iPath U.S. Treasury 10-Year Bull ETN\">DTYL</a>, <a href=\"https://seekingalpha.com/symbol/dlbl\" title=\"iPath U.S. Treasury Long Bond Bull ETN\">DLBL</a>, <a href=\"https://seekingalpha.com/symbol/iltb\" title=\"iShares Core Long-Term U.S. Bond ETF\">ILTB</a>, <a href=\"https://seekingalpha.com/symbol/tenz\" title=\"PIMCO 7-15 Year U.S. Treasury Index ETF\">TENZ</a>, <a href=\"https://seekingalpha.com/symbol/ite\" title=\"SPDR Barclays Intermediate Term Treasury ETF\">ITE</a>, <a href=\"https://seekingalpha.com/symbol/tlo\" title=\"SPDR Barclays Long Term Treasury ETF\">TLO</a>, <a href=\"https://seekingalpha.com/symbol/edv\" title=\"Vanguard Extended Duration Treasury ETF\">EDV</a>, <a href=\"https://seekingalpha.com/symbol/vgit\" title=\"Vanguard Intermediate-Term Government Bond Index ETF\">VGIT</a>, <a href=\"https://seekingalpha.com/symbol/vglt\" title=\"Vanguard Long-Term Government Bond Index ETF\">VGLT</a>, <a href=\"https://seekingalpha.com/symbol/tmf\" title=\"Direxion Daily 30-Year Treasury Bull 3x Shares ETF\">TMF</a>, <a href=\"https://seekingalpha.com/symbol/tyd\" title=\"Direxion Daily 10-Year Treasury Bull 3x Shares ETF\">TYD</a>, <a href=\"https://seekingalpha.com/symbol/lbnd\" title=\"PowerShares DB 3x Long 25+ Year Treasury Bond ETN\">LBND</a>, <a href=\"https://seekingalpha.com/symbol/ubt\" title=\"ProShares Ultra 20+ Year Treasury ETF\">UBT</a>, <a href=\"https://seekingalpha.com/symbol/ust\" title=\"ProShares Ultra 7-10 Year Treasury ETF\">UST</a>, <a href=\"https://seekingalpha.com/symbol/tmv\" title=\"Direxion Daily 30-Year Treasury Bear 3x Shares ETF\">TMV</a>, <a href=\"https://seekingalpha.com/symbol/tyo\" title=\"Direxion Daily 10-Year Treasury Bear 3x Shares ETF\">TYO</a>, <a href=\"https://seekingalpha.com/symbol/dstj\" title=\"JPMorgan Quarterly Double Short U.S. Long Bond Treasury Futures ETN\">DSTJ</a>, <a href=\"https://seekingalpha.com/symbol/dsxj\" title=\"JPMorgan Quarterly Double Short U.S. 10 Year Treasury Futures ETN\">DSXJ</a>, <a href=\"https://seekingalpha.com/symbol/sbnd\" title=\"PowerShares DB 3x Short 25+ Year Treasury Bond ETN\">SBND</a>, <a href=\"https://seekingalpha.com/symbol/pst\" title=\"ProShares UltraShort 7-10 Year Treasury ETF\">PST</a>, <a href=\"https://seekingalpha.com/symbol/tbt\" title=\"ProShares UltraShort 20+ Year Treasury ETF\">TBT</a>, <a href=\"https://seekingalpha.com/symbol/dtys\" title=\"iPath U.S. Treasury 10-Year Bear ETN\">DTYS</a>, <a href=\"https://seekingalpha.com/symbol/dlbs\" title=\"iPath U.S. Treasury Long Bond Bear ETN\">DLBS</a>, <a href=\"https://seekingalpha.com/symbol/tbf\" title=\"ProShares Short 20+ Year Treasury ETF\">TBF</a>, <a href=\"https://seekingalpha.com/symbol/ttt\" title=\"ProShares UltraPro Short 20+ Year Treasury ETF\">TTT</a>, <a href=\"https://seekingalpha.com/symbol/tyns\" title=\"Direxion Daily 7-10 Year Treasury Bear 1x ETF\">TYNS</a>, <a href=\"https://seekingalpha.com/symbol/tybs\" title=\"Direxion Daily 20+ Year Treasury Bear 1x ETF\">TYBS</a>, <a href=\"https://seekingalpha.com/symbol/tbx\" title=\"ProShares Short 7-10 Year Treasury ETF\">TBX</a>.</li>     <li>Stocks back off just a touch from earlier gains, the S&amp;P 500 (<a href=\"https://seekingalpha.com/symbol/spy\" title=\"SPDR S&amp;P 500 Trust ETF\">SPY</a> <font color=\"green\">+1.1%</font>), DJIA (<a href=\"https://seekingalpha.com/symbol/dia\" title=\"SPDR Dow Jones Industrial Average ETF\">DIA</a> <font color=\"green\">+0.7%</font>), Nasdaq 100 (<a href=\"https://seekingalpha.com/symbol/qqq\" title=\"PowerShares QQQ Trust ETF\">QQQ</a> <font color=\"green\">+1.3%</font>).</li>     <li>Index ETFs: <a href=\"https://seekingalpha.com/symbol/ivv\" title=\"iShares Core S&amp;P 500 ETF\">IVV</a>, <a href=\"https://seekingalpha.com/symbol/spy\" title=\"SPDR S&amp;P 500 Trust ETF\">SPY</a>, <a href=\"https://seekingalpha.com/symbol/voo\" title=\"Vanguard S&amp;P 500 ETF\">VOO</a>, <a href=\"https://seekingalpha.com/symbol/rwl\" title=\"RevenueShares Large Cap ETF\">RWL</a>, <a href=\"https://seekingalpha.com/symbol/sfla\" title=\"iPath Long Extended 3x S&amp;P 500 Index TR Index ETN\">SFLA</a>, <a href=\"https://seekingalpha.com/symbol/sso\" title=\"ProShares Ultra S&amp;P 500 ETF\">SSO</a>, <a href=\"https://seekingalpha.com/symbol/upro\" title=\"ProShares UltraPro S&amp;P 500 ETF\">UPRO</a>, <a href=\"https://seekingalpha.com/symbol/sds\" title=\"ProShares UltraShort S&amp;P 500 ETF\">SDS</a>, <a href=\"https://seekingalpha.com/symbol/spxu\" title=\"ProShares UltraPro Short S&amp;P 500 ETF\">SPXU</a>, <a href=\"https://seekingalpha.com/symbol/sh\" title=\"ProShares Short S&amp;P 500 ETF\">SH</a>, <a href=\"https://seekingalpha.com/symbol/eps\" title=\"WisdomTree Earnings 500 ETF\">EPS</a>, <a href=\"https://seekingalpha.com/symbol/rsp\" title=\"Guggenheim S&amp;P Equal Weight ETF\">RSP</a>, <a href=\"https://seekingalpha.com/symbol/bxub\" title=\"Barclays Capital Long B Leveraged Exchange Traded Notes Linked to the S&amp;P 500® Total Return Index\">BXUB</a>, <a href=\"https://seekingalpha.com/symbol/bxuc\" title=\"Barclays Capital Long C Leveraged Exchange Traded Notes Linked to the S&amp;P 500® Total Return Index\">BXUC</a>, <a href=\"https://seekingalpha.com/symbol/bxdb\" title=\"Barclays Capital Short B Leveraged Exchange Traded Notes Linked to the Inverse Performance of the S&amp;P 500® Total Return Index\">BXDB</a>, <a href=\"https://seekingalpha.com/symbol/dia\" title=\"SPDR Dow Jones Industrial Average ETF\">DIA</a>, <a href=\"https://seekingalpha.com/symbol/ddm\" title=\"ProShares Ultra Dow 30 ETF\">DDM</a>, <a href=\"https://seekingalpha.com/symbol/udow\" title=\"ProShares UltraPro Dow 30 ETF\">UDOW</a>, <a href=\"https://seekingalpha.com/symbol/dxd\" title=\"ProShares UltraShort Dow30 ETF\">DXD</a>, <a href=\"https://seekingalpha.com/symbol/sdow\" title=\"ProShares UltraPro Short Dow 30 ETF\">SDOW</a>, <a href=\"https://seekingalpha.com/symbol/dog\" title=\"ProShares Short Dow 30 ETF\">DOG</a>, <a href=\"https://seekingalpha.com/symbol/qqq\" title=\"PowerShares QQQ Trust ETF\">QQQ</a>, <a href=\"https://seekingalpha.com/symbol/qqew\" title=\"First Trust NASDAQ-100 Equal Weight Index ETF\">QQEW</a>, <a href=\"https://seekingalpha.com/symbol/tqqq\" title=\"ProShares UltraPro QQQ ETF\">TQQQ</a>, <a href=\"https://seekingalpha.com/symbol/qid\" title=\"ProShares UltraShort QQQ ETF\">QID</a>, <a href=\"https://seekingalpha.com/symbol/sqqq\" title=\"ProShares UltraPro Short QQQ ETF\">SQQQ</a>, <a href=\"https://seekingalpha.com/symbol/psq\" title=\"ProShares Short QQQ ETF\">PSQ</a>, <a href=\"https://seekingalpha.com/symbol/qld\" title=\"ProShares Ultra QQQ ETF\">QLD</a>, <a href=\"https://seekingalpha.com/symbol/qqqe\" title=\"Direxion NASDAQ-100 Equal Weighted Index Shares ETF\">QQQE</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1256922\" data-linked=\"Treasurys slide after fast ISM print\" data-tweet=\"$TLT $TLH $IEF - Treasurys slide after fast ISM print https://seekingalpha.com/news/1256922-treasurys-slide-after-fast-ism-print?source=tweet\" data-url=\"https://seekingalpha.com/news/1256922-treasurys-slide-after-fast-ism-print\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1256892\" data-ts=\"1378217012\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LF\" target=\"_blank\">LF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1256892-leapfrog-clipped-by-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LeapFrog clipped by downgrade</a></h4><ul> <li>Shares of Leapfrog (<a href=\"https://seekingalpha.com/symbol/LF\" title=\"LeapFrog Enterprises Inc.\">LF</a> <font color=\"red\">-5.6%</font>) stumble after BMO Capital <a href=\"http://www.minyanville.com/trading-and-investing/stocks/articles/Stock-Downgrades253A-Coca-Cola-Carries-The/9/3/2013/id/51546\" target=\"_blank\">lowers</a> its rating on the company to a Market Perform from Outperform on earnings concerns</li> <li>SA contributor Ashraf Eassa likes the <a href=\"https://seekingalpha.com/article/1668032-leapfrog-enterprises-a-conservative-guide-or-aggressive-sell-side-estimates\" target=\"_blank\">long-term potential</a> for LeapFrog, but sees an entry point of $7 to $8.50 being a safer level for investors.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1256892\" data-linked=\"LeapFrog clipped by downgrade\" data-tweet=\"$LF - LeapFrog clipped by downgrade https://seekingalpha.com/news/1256892-leapfrog-clipped-by-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/1256892-leapfrog-clipped-by-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1256872\" data-ts=\"1378216875\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVM\" target=\"_blank\">CVM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1256872-nyse-accepts-cel-scis-plan-to-return-to-compliance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NYSE accepts CEL-SCI&#39;s plan to return to compliance</a></h4><ul>   <li>The NYSE has accepted CEL-SCI's (<a href=\"https://seekingalpha.com/symbol/CVM\" title=\"Cel-Sci Corporation\">CVM</a> <font color=\"green\">+5.6%</font>) plan to bring itself into compliance with the exchange's listing standards and has granted the company an extension until September 30 to do so.</li>    <li>In July, the NYSE informed CEL-SCI that it wasn't in compliance with Section 1003(a)(iv) of its rules. The section states that the exchange will consider suspending or de-listing a company's whose losses are so great, or its financial situation so impaired, that it appears questionable as to whether it will be able to continue its operations or meet its obligations.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1256872\" data-linked=\"NYSE accepts CEL-SCI&#39;s plan to return to compliance\" data-tweet=\"$CVM - NYSE accepts CEL-SCI&#39;s plan to return to compliance https://seekingalpha.com/news/1256872-nyse-accepts-cel-scis-plan-to-return-to-compliance?source=tweet\" data-url=\"https://seekingalpha.com/news/1256872-nyse-accepts-cel-scis-plan-to-return-to-compliance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1256822\" data-ts=\"1378216546\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOK\" target=\"_blank\">NOK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1256822-a-roundup-of-tech-analyst-ratings-changes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">A roundup of tech analyst ratings changes</a></h4><ul>     <li>Nokia (<a href='https://seekingalpha.com/symbol/NOK' title='Nokia Corporation'>NOK</a> <font color='green'>+38.5%</font>) has been upgraded to neutral ratings by Credit Suisse, Bernstein, and Oppenheimer following the <a href=\"https://seekingalpha.com/currents/search?query=nok%20msft\" target=\"_blank\">Microsoft deal</a>.</li><li>Vodafone (<a href='https://seekingalpha.com/symbol/VOD' title='Vodafone Group Plc'>VOD</a> <font color='red'>-3%</font>) has been upgraded to Market Perform by Bernstein, and cut to Neutral by Macquarie, in the wake of the <a href=\"https://seekingalpha.com/currents/post/1255742\" target=\"_blank\">Verizon deal</a>.</li>     <li>Canadian carriers BCE (<a href='https://seekingalpha.com/symbol/BCE' title='BCE Inc.'>BCE</a> <font color='green'>+4.4%</font>) and Telus (<a href='https://seekingalpha.com/symbol/TU' title='TELUS Corporation'>TU</a> <font color='green'>+6.8%</font>) have been upgraded to Outperform in response to Verizon/Vodafone, and Verizon's subsequent assertion it <a href=\"https://seekingalpha.com/currents/post/1255882\" target=\"_blank\">has no plans</a> to enter Canada.</li>     <li>AT&amp;T (<a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a> <font color='green'>+0.6%</font>) has been upgraded to Neutral by Macquarie.</li>     <li>Palo Alto Networks (<a href='https://seekingalpha.com/symbol/PANW' title='Palo Alto Networks'>PANW</a> <font color='red'>-1.5%</font>) has been downgraded to Market Perform by JMP.</li><li>Cvent (<a href='https://seekingalpha.com/symbol/CVT' title='Cvent, Inc.'>CVT</a> <font color='green'>+1.4%</font>) has received three bullish ratings and one neutral one, and YuMe (<a href='https://seekingalpha.com/symbol/YUME' title='YuMe, Inc.'>YUME</a> <font color='green'>+1.5%</font>) has received four bullish ratings, as underwriters launch post-IPO coverage.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1256822\" data-linked=\"A roundup of tech analyst ratings changes\" data-tweet=\"$NOK $NOK $VOD - A roundup of tech analyst ratings changes https://seekingalpha.com/news/1256822-a-roundup-of-tech-analyst-ratings-changes?source=tweet\" data-url=\"https://seekingalpha.com/news/1256822-a-roundup-of-tech-analyst-ratings-changes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1256812\" data-ts=\"1378216296\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYTK\" target=\"_blank\">CYTK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1256812-cytokinetics-punished-but-omecamtiv-mecarbil-results-not-surprising\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cytokinetics punished, but omecamtiv mecarbil results not surprising</a></h4><ul>\n<li>Shares of Cytokinetics (<a href=\"https://seekingalpha.com/symbol/CYTK\" title=\"Cytokinetics, Incorporated\">CYTK</a> <font color=\"red\">-20.8%</font>) are getting punished today after  omecamtiv mecarbil \u2014 developed with Amgen (<a href=\"https://seekingalpha.com/symbol/AMGN\" title=\"Amgen Inc.\">AMGN</a> <font color=\"green\">+1.4%</font>) \u2014 <a href=\"https://seekingalpha.com/currents/post/1256042\" target=\"_blank\">missed its primary endpoint</a> in a Phase 2 acute heart failure trial.</li>\n<li>Investors <a href=\"http://www.thestreet.com/story/12023870/1/amgen-cytokinetics-report-mixed-results-for-heart-failure-drug.html\" target=\"_blank\">shouldn't necessarily be surprised</a>, <em>theStreet</em>'s Adam Feuerstein writes, noting that both companies \"had been warning investors not to expect a statistically significant  improvement in overall dypsnea response because the lowest dose of  omecamtiv mecarbil tested was thought to be sub-therapeutic.\"</li>\n<li>Leerink <a href=\"http://www.streetinsider.com/Analyst+Comments/Cytokinetics+%28CYTK%29++Amgen+%28AMGN%29+Omecamtiv+Data+In-line+With+Expectations+-+Leerink+Swann/8652649.html\" target=\"_blank\">agrees</a>. \"These results are in line with our expectations since the study was underpowered to hit its primary endpoint,\" analyst Joseph Schwartz says.</li>\n<li>Both Leerink and Feuerstein point out that the highest dose of omecamtiv mecarbil performed better.</li>\n<li>While investors await data from COSMIC, it's worth noting the following comment from CYTK CEO Robert Blum: \"We're impressed and pleased with the study results because the drug behaved consistent with what we've seen in previous studies.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1256812\" data-linked=\"Cytokinetics punished, but omecamtiv mecarbil results not surprising\" data-tweet=\"$CYTK $CYTK $AMGN - Cytokinetics punished, but omecamtiv mecarbil results not surprising https://seekingalpha.com/news/1256812-cytokinetics-punished-but-omecamtiv-mecarbil-results-not-surprising?source=tweet\" data-url=\"https://seekingalpha.com/news/1256812-cytokinetics-punished-but-omecamtiv-mecarbil-results-not-surprising\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1256782\" data-ts=\"1378215806\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBS\" target=\"_blank\">CBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1256782-cbs-rallies-following-favorable-cable-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CBS rallies following favorable cable deal</a></h4><ul> <li>Shares of CBS (NYSE:<a href=\"https://seekingalpha.com/symbol/CBS\" title=\"CBS Corporation\">CBS</a>) shoot <font color=\"green\">up 4%</font> on the open as the company's <a href=\"https://seekingalpha.com/currents/search?query=cbs%20twc\" target=\"_blank\">deal</a> with Time Warner Cable is seen as highly favorable to its side of the ledger.</li> <li>Beyond just working out a per subscriber carriage rate reportedly close to what it was asking for, CBS also <a href=\"http://adage.com/article/media/cbs-deal-ends-time-warner-cable-blackout-ahead-nfl/243939/\" target=\"_blank\">retained rights</a> to online programming which it can sell on an exclusive basis to a new service from Google, Sony, or Apple it if desires.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1256782\" data-linked=\"CBS rallies following favorable cable deal\" data-tweet=\"$CBS $VIAC - CBS rallies following favorable cable deal https://seekingalpha.com/news/1256782-cbs-rallies-following-favorable-cable-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/1256782-cbs-rallies-following-favorable-cable-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1256752\" data-ts=\"1378215341\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVNR\" target=\"_blank\">AVNR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1256752-avanir-actavis-in-deal-over-nuedexta\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avanir, Actavis in deal over Nuedexta</a></h4><ul>   <li>Avanir Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/AVNR\" title=\"Avanir Pharmaceuticals, Inc\">AVNR</a> <font color=\"green\">+5.5%</font>) enters into a settlement with Actavis (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ACT\" title=\"AdvisorShares Vice ETF\">ACT</a>) to resolve patent litigation that followed the latter's application to market generic versions of Avanir's Nuedexta treatment for pseudobulbar affect (PBA), a neurological condition that causes sufferers to laugh or cry uncontrollably,</li>    <li>Actavis will be allowed to start selling copycat Nuedexta  from July 2026.</li>    <li>The deal follows one that Avanir <a href=\"https://seekingalpha.com/currents/post/1221042\" target=\"_blank\">recently struck</a> with Sandoz. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1256752\" data-linked=\"Avanir, Actavis in deal over Nuedexta\" data-tweet=\"$AVNR $AVNR $AGN - Avanir, Actavis in deal over Nuedexta https://seekingalpha.com/news/1256752-avanir-actavis-in-deal-over-nuedexta?source=tweet\" data-url=\"https://seekingalpha.com/news/1256752-avanir-actavis-in-deal-over-nuedexta\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1256672\" data-ts=\"1378214604\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TM\" target=\"_blank\">TM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1256672-japan-soars-as-yen-renews-fast-decline\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Japan soars as yen renews fast decline</a></h4><ul>     <li>Japan overnight had its <a href=\"http://www.bloomberg.com/news/2013-09-03/japanese-shares-rise-on-weaker-yen-global-recovery-signs.html\" target=\"_blank\">biggest gain in a month</a>, the Nikkei <font color=\"green\">+3%</font> to add to Monday's <font color=\"green\">1.4% advance</font>. The yen has fallen sharply over the past few sessions, with the dollar buying ¥99.29 this morning vs. just ¥97 towards the end of last week. The weaker yen helped Toyota (<a href=\"https://seekingalpha.com/symbol/TM\" title=\"Toyota Motor Corporation\">TM</a> <font color=\"green\">+2.9%</font> premarket) to be the Nikkei's biggest gainer. Kansai Electric <font color=\"green\">soared 8.1%</font> after an expert panel concluded an earthquake fault under the company's Ohi nuclear plant may not be active.</li>     <li>\n<a href=\"https://seekingalpha.com/symbol/EWJ\" title=\"iShares MSCI Japan ETF\">EWJ</a><font color=\"green\"> +2.9%</font>, <a href=\"https://seekingalpha.com/symbol/DXJ\" title=\"WisdomTree Japan Hedged Equity ETF\">DXJ</a> <font color=\"green\">+3.8%</font> premarket.</li>     <li>Equity and JGB ETFs: <a href=\"https://seekingalpha.com/symbol/EWJ\" title=\"iShares MSCI Japan ETF\">EWJ</a>, <a href=\"https://seekingalpha.com/symbol/NKY\" title=\"Precidian MAXIS Nikkei 225 Index ETF\">NKY</a>, <a href=\"https://seekingalpha.com/symbol/EWV\" title=\"ProShares UltraShort MSCI Japan ETF\">EWV</a>, <a href=\"https://seekingalpha.com/symbol/EZJ\" title=\"ProShares Ultra MSCI Japan ETF\">EZJ</a>, ITF, <a href=\"https://seekingalpha.com/symbol/JSC\" title=\"SPDR Russell/Nomura Small Cap Japan ETF\">JSC</a>, <a href=\"https://seekingalpha.com/symbol/JPP\" title=\"SPDR Russell/Nomura PRIME Japan ETF\">JPP</a>, <a href=\"https://seekingalpha.com/symbol/DXJ\" title=\"WisdomTree Japan Hedged Equity ETF\">DXJ</a>, <a href=\"https://seekingalpha.com/symbol/SCJ\" title=\"iShares MSCI Japan Small-Cap ETF\">SCJ</a>, <a href=\"https://seekingalpha.com/symbol/DFJ\" title=\"WisdomTree Japan SmallCap Dividend ETF\">DFJ</a>, <a href=\"https://seekingalpha.com/symbol/FJP\" title=\"First Trust Japan AlphaDEX ETF\">FJP</a>, <a href=\"https://seekingalpha.com/symbol/JPNL\" title=\"Direxion Daily Japan Bull 3x Shares ETF\">JPNL</a>, <a href=\"https://seekingalpha.com/symbol/JPNS\" title=\"Direxion Daily Japan Bear 3x Shares ETF\">JPNS</a>, <a href=\"https://seekingalpha.com/symbol/DXJS\" title=\"WisdomTree Japan Hedged SmallCap Equity ETF\">DXJS</a>, <a href=\"https://seekingalpha.com/symbol/JGBT\" title=\"DB 3x Japanese Govt Bond Futures ETN\">JGBT</a>, <a href=\"https://seekingalpha.com/symbol/JGBL\" title=\"DB Japanese Govt Bond Futures ETN\">JGBL</a>, <a href=\"https://seekingalpha.com/symbol/JGBS-OLD\" title=\"DB Inverse Japanese Govt. Bond Futures ETN\">JGBS-OLD</a>, <a href=\"https://seekingalpha.com/symbol/JGBD\" title=\"DB 3x Inverse Japanese Govt. Bond Futures ETN\">JGBD</a>.</li>     <li>Currency: <a href=\"https://seekingalpha.com/symbol/FXY\" title=\"Invesco CurrencyShares Japanese Yen Trust ETF\">FXY</a>, <a href=\"https://seekingalpha.com/symbol/JYN\" title=\"iPath JPY/USD Exchange Rate ETN\">OTC:JYN</a>, <a href=\"https://seekingalpha.com/symbol/YCL\" title=\"ProShares Ultra Yen ETF\">YCL</a>, <a href=\"https://seekingalpha.com/symbol/YCS\" title=\"ProShares UltraShort Yen ETF\">YCS</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1256672\" data-linked=\"Japan soars as yen renews fast decline\" data-tweet=\"$TM $TM $EWJ - Japan soars as yen renews fast decline https://seekingalpha.com/news/1256672-japan-soars-as-yen-renews-fast-decline?source=tweet\" data-url=\"https://seekingalpha.com/news/1256672-japan-soars-as-yen-renews-fast-decline\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1256642\" data-ts=\"1378214351\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CKSW\" target=\"_blank\">CKSW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1256642-clicksoftware-co-ceo-resigns-shares-minus-3_8-percent-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ClickSoftware co-CEO resigns, shares -3.8% premarket</a></h4><ul>\n<li>Hannan Cameli, a 13-year company vet who was ClickSoftware's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CKSW\" title=\"ClickSoftware Technologies Ltd.\">CKSW</a>) COO before being named co-CEO in June, is resigning from his position, and from the company's board. The resignation leaves founder Moshe BenBassat as Click's only CEO. (PR)</li>\n<li>Chairman Israel Borovich: \"The Board determined that having two leaders at the top of the Company was not practical, and that it was in the Company's best interest to revert back to a more conventional structure.\"</li>\n<li>The workforce management software vendor adds it has signed \"several new contracts\" in Q3, including \"two significant cloud-based deals with new customers.\"</li>\n<li>Click shares <a href=\"https://seekingalpha.com/currents/post/1124842\" target=\"_blank\">tumbled in July</a> thanks to a Q2 warning.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1256642\" data-linked=\"ClickSoftware co-CEO resigns, shares -3.8% premarket\" data-tweet=\"$CKSW - ClickSoftware co-CEO resigns, shares -3.8% premarket https://seekingalpha.com/news/1256642-clicksoftware-co-ceo-resigns-shares-minus-3_8-percent-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/1256642-clicksoftware-co-ceo-resigns-shares-minus-3_8-percent-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1256592\" data-ts=\"1378213972\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1256592-premarket-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/NOK' title='Nokia Corporation'>NOK</a> <font color='green'>+41%</font>. ALU <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/HALO' title='Halozyme Therapeutics, Inc.'>HALO</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/LOGI' title='Logitech International S.A.'>LOGI</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/GTXI' title='GTx, Inc.'>GTXI</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/RIO' title='Rio Tinto plc'>RIO</a> <font color='green'>+6%</font>. ISIS <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/STM' title='STMicroelectronics NV'>STM</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/NEON' title='Neonode, Inc.'>NEON</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/ERIC' title='LM Ericsson Telephone Company'>ERIC</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ARQL' title='ArQule, Inc.'>ARQL</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/CYTK' title='Cytokinetics, Incorporated'>CYTK</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/STP' title='Suntech Power Holdings Co., Ltd.'>STP</a> <font color='red'>-12%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"1256592\" data-linked=\"Premarket Gainers / Losers\" data-tweet=\"$NOK $HALO $LOGI - Premarket Gainers / Losers https://seekingalpha.com/news/1256592-premarket-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1256592-premarket-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1256542\" data-ts=\"1378213358\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RHHBY\" target=\"_blank\">RHHBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1256542-roche-gets-authorization-for-sub-q-herceptin-good-news-for-halozyme\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Roche gets authorization for sub-Q Herceptin, good news for Halozyme</a></h4><ul>     <li>The European Commission grants Roche (<a href=\"https://seekingalpha.com/symbol/RHHBY\" title=\"Roche Holding Ltd ADR\">OTCQX:RHHBY</a>) marketing authorization for a time-saving sub-Q version of Herceptin which uses Halozyme Therapeutics' (NASDAQ:<a href=\"https://seekingalpha.com/symbol/HALO\" title=\"Halozyme Therapeutics, Inc.\">HALO</a>) rHuPH20.</li>     <li>The administration takes just two to five minutes versus 30-90 minutes with the IV form. (PR)</li>     <li>SA contributor StockMatusow <a href=\"https://seekingalpha.com/article/1660952-the-baker-brothers-increase-shares-in-halozyme-by-105-insider-makes-big-buy-and-options-heat-up\" target=\"_blank\">recommended HALO shares</a> last week, in part based on what he believed was a forthcoming approval for sub-Q Herceptin.</li>     <li>HALO <font color=\"green\">+9.5%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1256542\" data-linked=\"Roche gets authorization for sub-Q Herceptin, good news for Halozyme\" data-tweet=\"$RHHBY $RHHBY $HALO - Roche gets authorization for sub-Q Herceptin, good news for Halozyme https://seekingalpha.com/news/1256542-roche-gets-authorization-for-sub-q-herceptin-good-news-for-halozyme?source=tweet\" data-url=\"https://seekingalpha.com/news/1256542-roche-gets-authorization-for-sub-q-herceptin-good-news-for-halozyme\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1256492\" data-ts=\"1378213092\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KEG\" target=\"_blank\">KEG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1256492-key-energy-plus-2_8-percent-after-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Key Energy +2.8% after upgrade</a></h4><ul>     <li>Key Energy Services (NYSE:<a href=\"https://seekingalpha.com/symbol/KEG\" title=\"Key Energy Services, Inc.\">KEG</a>) <font color=\"green\">+2.8%</font> premarket after Global Hunter <a href=\"http://www.streetinsider.com/Upgrades/Global+Hunter+Securities+Upgrades+Key+Energy+Services+%28KEG%29+to+Buy/8652621.html\" target=\"_blank\">upgrades</a> shares to Buy from Neutral and raises its target price to $8.50 from $7.25.</li>     <li>The firm says it feels much more confident about the progression of margins at both the field and corporate level, and KEG's aggressive leaning out of the operation should lead to improved results in a flat operating environment and establish a solid base for incremental margins in excess of its peers.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1256492\" data-linked=\"Key Energy +2.8% after upgrade\" data-tweet=\"$KEG - Key Energy +2.8% after upgrade https://seekingalpha.com/news/1256492-key-energy-plus-2_8-percent-after-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/1256492-key-energy-plus-2_8-percent-after-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1256472\" data-ts=\"1378212627\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IBN\" target=\"_blank\">IBN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1256472-india-tumbles-amid-downgrade-worry\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">India tumbles amid downgrade worry</a></h4><ul>     <li>The Sensex broke a 3-day winning streak, <font color=\"red\">tumbling 3.5%</font> as the rupee fell as much as 2% amid worries India is <a href=\"http://economictimes.indiatimes.com/markets/stocks/market-news/us-syria-tensions-create-panic-sensex-ends-651-pts-lower/articleshow/22256428.cms\" target=\"_blank\">set to be downgraded</a>. An S&amp;P report says the chances of an Indian downgraded are higher than those for Indonesia.</li>     <li>Goldman cuts its fiscal year GDP growth forecast to 4% from 6%, and now expects the rupee to fall as low as 72 to the dollar in the next 6 months. It takes just more than 67 rupees to buy a greenback at the moment.</li>     <li>\n<a href=\"https://seekingalpha.com/symbol/EPI\" title=\"WisdomTree India Earnings ETF\">EPI</a> <font color=\"red\">-3.4%</font> premarket.</li>     <li>ICICI Bank (NYSE:<a href=\"https://seekingalpha.com/symbol/IBN\" title=\"ICICI Bank Ltd.\">IBN</a>) <font color=\"red\">-3.5%</font>, HDFC Bank (NYSE:<a href=\"https://seekingalpha.com/symbol/HDB\" title=\"HDFC Bank Limited\">HDB</a>) <font color=\"red\">-3.8%</font> premarket.</li>     <li>Equity ETFs: <a href=\"https://seekingalpha.com/symbol/INDY\" title=\"iShares S&amp;P India Nifty Fifty Index ETF\">INDY</a>, <a href=\"https://seekingalpha.com/symbol/EPI\" title=\"WisdomTree India Earnings ETF\">EPI</a>, <a href=\"https://seekingalpha.com/symbol/PIN\" title=\"Invesco India Portfolio ETF\">PIN</a>, <a href=\"https://seekingalpha.com/symbol/INP\" title=\"iPath MSCI India Index ETN\">INP</a>, <a href=\"https://seekingalpha.com/symbol/INDA\" title=\"iShares MSCI India Index ETF\">INDA</a>, <a href=\"https://seekingalpha.com/symbol/INXX\" title=\"Columbia India Infrastructure ETF\">INXX</a>, <a href=\"https://seekingalpha.com/symbol/SCIF\" title=\"VanEck Vectors India Small-Cap Index ETF\">SCIF</a>, <a href=\"https://seekingalpha.com/symbol/SCIN\" title=\"Columbia India Small Cap ETF\">SCIN</a>, <a href=\"https://seekingalpha.com/symbol/INDL\" title=\"Direxion Daily India 3x Bull Shares ETF\">INDL</a>, <a href=\"https://seekingalpha.com/symbol/SMIN\" title=\"iShares MSCI India Small Cap Index ETF\">SMIN</a>.</li>     <li>Rupee: <a href=\"https://seekingalpha.com/symbol/ICN\" title=\"WisdomTree Indian Rupee Strategy Fund\">ICN</a>, <a href=\"https://seekingalpha.com/symbol/INR\" title=\"Market Vectors Indian Rupee/USD ETN\">INR</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1256472\" data-linked=\"India tumbles amid downgrade worry\" data-tweet=\"$IBN $EPI $IBN - India tumbles amid downgrade worry https://seekingalpha.com/news/1256472-india-tumbles-amid-downgrade-worry?source=tweet\" data-url=\"https://seekingalpha.com/news/1256472-india-tumbles-amid-downgrade-worry\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1256442\" data-ts=\"1378212387\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NEON\" target=\"_blank\">NEON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1256442-neonode-exploring-strategic-alternatives-for-user-interface-ip\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neonode exploring strategic alternatives for user interface IP</a></h4><ul>     <li>Neonode (NASDAQ:<a href=\"https://seekingalpha.com/symbol/NEON\" title=\"Neonode, Inc.\">NEON</a>) rises <font color=\"green\">5%</font> premarket after saying its board has approved to exploration of strategic alternatives for its user-interface patent and licensing subsidiary.</li>     <li>\"NEON is a pioneer in the touch screen user-interface area, and ... has built up significant IP, software and know-how in  this field. We think that a more dedicated focus on the development and  monetization of this IP would be beneficial for our shareholders,\" CEO Thomas Eriksson says. (PR)<br>     </li> </ul><div class=\"tiny-share-widget\" data-id=\"1256442\" data-linked=\"Neonode exploring strategic alternatives for user interface IP\" data-tweet=\"$NEON - Neonode exploring strategic alternatives for user interface IP https://seekingalpha.com/news/1256442-neonode-exploring-strategic-alternatives-for-user-interface-ip?source=tweet\" data-url=\"https://seekingalpha.com/news/1256442-neonode-exploring-strategic-alternatives-for-user-interface-ip\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1256292\" data-ts=\"1378210301\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSFT\" target=\"_blank\">MSFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1256292-microsoft-tumbles-following-nokia-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microsoft tumbles following Nokia deal</a></h4><ul>     <li>Microsoft (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MSFT\" title=\"Microsoft Corporation\">MSFT</a>) <font color=\"red\">tumbles 4.5%</font> premarket after <a href=\"https://seekingalpha.com/currents/post/1255792\" target=\"_blank\">agreeing to buy</a> Nokia's handset business for $7.2B. The sell side isn't terribly enthusiastic.</li>     <li>\"Nokia deal not likely well-received by shareholders,\" <a href=\"https://twitter.com/thenotablecalls/status/374846855454011392\" target=\"_blank\">says</a> Rick Sherlund who just <a href=\"https://seekingalpha.com/currents/post/1237572\" target=\"_blank\">upgraded</a> MSFT 10 days ago. \"New management is unlikely to simply break up the company.\"</li>     <li>We see this acquisition as incrementally negative,\" <a href=\"https://twitter.com/thenotablecalls/status/374847509517963264\" target=\"_blank\">says</a> Bernstein. Doubling down on mobile phones highlights lack of attention on the enterprise side.</li>     <li>A \"hail mary pass,\" <a href=\"http://www.streetinsider.com/Private+Equity/Nokia+%28NOK%29+Deal+is+Hail+Mary+Pass+for+Microsoft+%28MSFT%29+-+Oppenheimer/8652216.html\" target=\"_blank\">says Oppenheimer's Shaul Eyal</a>. The transaction is a \"call option on mobile,\" he says, where Microsoft stands to maybe see a positive result without risking too much money. The catalysts of a dividend hike, a potential new CEO, and shareholder activism could outweigh any negativity from this deal, he hopes, maintaining his Buy rating and $37 price target.</li>     <li>\n<a href=\"https://seekingalpha.com/symbol/NOK\" title=\"Nokia Corporation\">NOK</a><font color=\"green\"> +45%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1256292\" data-linked=\"Microsoft tumbles following Nokia deal\" data-tweet=\"$MSFT $MSFT $NOK - Microsoft tumbles following Nokia deal https://seekingalpha.com/news/1256292-microsoft-tumbles-following-nokia-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/1256292-microsoft-tumbles-following-nokia-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1256172\" data-ts=\"1378208973\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STP\" target=\"_blank\">STP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1256172-suntech-prepares-asset-sale-takeover-by-major-investor-shares-minus-34-percent\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Suntech prepares asset sale, takeover by major investor; shares -34%</a></h4><ul>     <li>Suntech Power (NYSE:<a href=\"https://seekingalpha.com/symbol/STP\" title=\"Suntech Power Holdings Co., Ltd.\">STP</a>) <font color=\"red\">-34%</font> premarket after Friday night's announcement of an \"understanding\" with creditors that will allow a conversion of debt to equity and the introduction of a strategic investor who will offer funds through buying new shares.</li>     <li>\"The restructuring will allow us to cut our costs and optimize our margins and production,\" STP's Zhou Weiping says. \"Although there is expected to be substantial dilution for our existing shareholders, we believe that these measures will put us in a better and stronger position.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"1256172\" data-linked=\"Suntech prepares asset sale, takeover by major investor; shares -34%\" data-tweet=\"$STP - Suntech prepares asset sale, takeover by major investor; shares -34% https://seekingalpha.com/news/1256172-suntech-prepares-asset-sale-takeover-by-major-investor-shares-minus-34-percent?source=tweet\" data-url=\"https://seekingalpha.com/news/1256172-suntech-prepares-asset-sale-takeover-by-major-investor-shares-minus-34-percent\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1256152\" data-ts=\"1378208679\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ING\" target=\"_blank\">ING</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1256152-another-sell-side-buy-rating-for-ing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Another sell-side Buy rating for ING</a></h4><ul>     <li>\n<a href=\"https://seekingalpha.com/symbol/ING\" title=\"ING Groep N.V.\">ING</a> is initiated a Buy at UBS.</li>     <li>The bank <a href=\"https://seekingalpha.com/currents/post/1238852\" target=\"_blank\">was the recipient</a> of numerous upgrades in August following Q2 earnings which showed the company making great progress on its restructuring efforts. The stock gained 6.8% in August as broad equity markets retreated.</li>\n<li>Progress continued last week as ING<a href=\"https://seekingalpha.com/currents/post/1242402\" target=\"_blank\"> finally unloaded</a> its South Korean insurance unit.</li>     <li>Shares <font color=\"green\">+1.2%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1256152\" data-linked=\"Another sell-side Buy rating for ING\" data-tweet=\"$ING - Another sell-side Buy rating for ING https://seekingalpha.com/news/1256152-another-sell-side-buy-rating-for-ing?source=tweet\" data-url=\"https://seekingalpha.com/news/1256152-another-sell-side-buy-rating-for-ing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1256042\" data-ts=\"1378206465\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMGN\" target=\"_blank\">AMGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1256042-amgen-cytokinetics-heart-drug-fails-to-add-puff\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amgen, Cytokinetics heart drug fails to add puff</a></h4><ul>   <li>An intravenous version of Amgen's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AMGN\" title=\"Amgen Inc.\">AMGN</a>) and Cytokinetics' (<a href=\"https://seekingalpha.com/symbol/CYTK\" title=\"Cytokinetics, Incorporated\">CYTK</a> <font color=\"red\">-17.3%</font>) Omecamtiv Mecarbil treatment  <a href=\"http://www.reuters.com/article/2013/09/03/heart-amgen-idUSL6N0GX0KU20130903\" target=\"_blank\">missed its target</a> of improving shortness of breath in heart-failure patients in a Phase II trial.</li>    <li>However, Amgen plans to continue testing an oral version in a separate Phase II study. The companies will use the combined results to determine whether to take Omecamtiv Mecarbil into Phase III testing. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1256042\" data-linked=\"Amgen, Cytokinetics heart drug fails to add puff\" data-tweet=\"$AMGN $AMGN $CYTK - Amgen, Cytokinetics heart drug fails to add puff https://seekingalpha.com/news/1256042-amgen-cytokinetics-heart-drug-fails-to-add-puff?source=tweet\" data-url=\"https://seekingalpha.com/news/1256042-amgen-cytokinetics-heart-drug-fails-to-add-puff\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1255922\" data-ts=\"1378200423\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ERIC\" target=\"_blank\">ERIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1255922-ericsson-alcatel-lucent-rise-following-nokia-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ericsson, Alcatel-Lucent rise following Nokia deal</a></h4><ul>   <li>Ericsson (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ERIC\" title=\"LM Ericsson Telephone Company\">ERIC</a>) and Alcatel-Lucent (ALU) jump sharply following news that Nokia (NYSE:<a href=\"https://seekingalpha.com/symbol/NOK\" title=\"Nokia Corporation\">NOK</a>) is <a href=\"https://seekingalpha.com/currents/search?query=nokia%20microsoft\" target=\"_blank\">selling its handset unit</a> to Microsoft, leaving the Finnish company to focus on its telecom-equipment division NSN, among other things. Could industry consolidation be on the cards?</li>    <li>As SA auther Jacob Steinberg notes, the deal will leave Nokia with a <a href=\"https://seekingalpha.com/article/1668932-my-take-on-microsofts-nokia-acquisition\" target=\"_blank\">cash mountain of almost $20B</a>. That would theoretically be more than enough to buy Alcatel-Lucent, whose market cap is just $5.86B.</li>\n<li>Ericsson is <font color=\"green\">+3.9%</font> in Stockholm and ALU is <font color=\"green\">+11.2%</font> premarket in the U.S.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1255922\" data-linked=\"Ericsson, Alcatel-Lucent rise following Nokia deal\" data-tweet=\"$ERIC $ERIC $NOK - Ericsson, Alcatel-Lucent rise following Nokia deal https://seekingalpha.com/news/1255922-ericsson-alcatel-lucent-rise-following-nokia-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/1255922-ericsson-alcatel-lucent-rise-following-nokia-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1255912\" data-ts=\"1378199776\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1255912-asian-shares-rise-europe-fall\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Asian shares rise, Europe fall</a></h4><ul>     <li><a href=\"http://www.marketwatch.com/story/european-stocks-struggle-after-rally-nokia-surges-2013-09-03?siteid=rss&amp;rss=1\" target=\"_blank\">European</a> and <a href=\"http://www.bloomberg.com/news/2013-09-03/asian-stocks-rise-fourth-day-on-global-economic-recovery.html\" target=\"_blank\">Asian</a> stocks take mostly divergent paths, with the latter boosted by strong <a href=\"https://seekingalpha.com/currents/search?query=pmi\" target=\"_blank\">PMI data</a> out of China and Europe.</li>     <li>European shares are largely in the red following a strong rally yesterday.</li>     <li>Nokia is <font color='green'>+37%</font> in Helsinki following its deal with Microsoft, while other telecom-equipment companies such as Ericsson (<font color='green'>+3.9%</font>) and Alcatel-Lucent (<font color='green'>+8.1%</font>) are also rising.</li>     <li>Japan <font color='green'>+3%</font>, Hong Kong <font color='green'>+1%</font>, China <font color='green'>+1.2%</font>, India <font color='red'>-2.8%</font>.</li>     <li>EU Stoxx 50 <font color='red'>-0.5%</font>, London <font color='red'>-0.4%</font>, Paris <font color='red'>-0.8%</font>, Frankfurt <font color='red'>-0.7%</font>, Milan <font color='red'>-0.4%</font>, Madrid <font color='red'>-0.2%</font>.</li>     <li>U.S. stock futures: Dow <font color='green'>+0.55%</font>. S&amp;P <font color='green'>+0.7%</font>. Nasdaq <font color='green'>+0.6%</font></li> </ul><div class=\"tiny-share-widget\" data-id=\"1255912\" data-linked=\"Asian shares rise, Europe fall\" data-tweet=\"Asian shares rise, Europe fall https://seekingalpha.com/news/1255912-asian-shares-rise-europe-fall?source=tweet\" data-url=\"https://seekingalpha.com/news/1255912-asian-shares-rise-europe-fall\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1255892\" data-ts=\"1378198029\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOK\" target=\"_blank\">NOK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1255892-nokia-soars-following-microsoft-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nokia soars following Microsoft deal</a></h4><ul>   <li>Nokia (NYSE:<a href=\"https://seekingalpha.com/symbol/NOK\" title=\"Nokia Corporation\">NOK</a>) shares <font color=\"green\">jump 37%</font> in Helsinki following news that it's selling its mobile phone unit to Microsoft (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MSFT\" title=\"Microsoft Corporation\">MSFT</a>) as part of a <a href=\"https://seekingalpha.com/currents/search?query=nokia%20microsoft\" target=\"_blank\">deal worth $7.17B</a>.</li>    <li>SA author Charles Fox reckons a major motive behind the transaction is that Nokia CEO Stephen Elop is now a dead certainty to replace Steve Ballmer as Microsoft boss.</li>    <li>Shorn of a big loss maker and sitting on a nice cash mountain, the <a href=\"https://seekingalpha.com/article/1668922-the-stars-have-finally-aligned-microsoft-buys-a-chunk-of-nokia-and-why-you-should-hold-on\" target=\"_blank\">future seems bright</a> for Nokia, although its potential could now be limited.</li>    <li>Some might think that Microsoft is overpaying for a business \"many investors and analysts wrote off as dead,\" but Fox thinks $5B \"seems like chump change for a...division that once ruled the phone market\" and could come back.</li>    <li>Jacob Steinberg echoes these sentiments. \"Nokia's phone business deserves a <a href=\"https://seekingalpha.com/article/1668932-my-take-on-microsofts-nokia-acquisition\" target=\"_blank\">much better price</a> than $5B considering how it generated $20.38B in revenues last year,\" says Steinberg.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1255892\" data-linked=\"Nokia soars following Microsoft deal\" data-tweet=\"$NOK $NOK $MSFT - Nokia soars following Microsoft deal https://seekingalpha.com/news/1255892-nokia-soars-following-microsoft-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/1255892-nokia-soars-following-microsoft-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":69,"message":null,"success":true,"today":{"start":1576818000,"end":1576904399,"str":"Friday, December 20, 2019"},"yesterday":{"start":1576731600,"end":1576817999}}